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Abstract 
Mild hypothermia at 32-35
o
C (HT) has been shown to be neuroprotective for neurological 
emergencies following severe head trauma, cardiac arrest and neonatal asphyxia. 
However, HT has not been widely deployed in clinical settings because: firstly, cooling 
the whole body below 33-34°C can induce severe complications; therefore, applying HT 
selectively to the brain could minimize adverse effects by maintaining core body 
temperature at normal level. Secondly, development of an effective and easy to 
implement selective brain cooling (SBC) technique, which can quickly induce brain 
hypothermia while avoiding complications from whole body cooling, remains a 
challenge. In this thesis, we studied the feasibility and efficiency of selective brain 
cooling (SBC) through nasopharyngeal cooling. To control the cooling and rewarming 
rate and because core body temperature is different from brain temperature, we also 
developed a non-invasive technique based on time-resolved near infrared spectroscopy 
(TR-NIRS) to measure local brain temperature.  In normal brain, cerebral blood flow 
(CBF) and energy metabolism as reflected by the cerebral metabolic rate of oxygen 
(CMRO2) is tightly coupled leading to an oxygen extraction efficiency (OEF) of around 
~33%. A decoupling of the two as in ischemia signifies oxidative stress and would lead to 
an increase in OEF beyond the normal value of ~33%. The final goal of this thesis is to 
evaluate TR-NIRS methods for measurements of CBF and CMRO2 to monitor for 
oxidative metabolism in the brain with and without HT treatment. 
 Chapter 2 presents investigations on the feasibility and efficiency of the 
nasopharyngeal SBC by blowing room temperature or humidified cooled air into the 
nostrils. Effective brain cooling at a median cooling rate of 5.6 ± 1.1°C/hour compared to 
whole body cooling rate of 3.2 ± 0.7 was demonstrated with the nasopharyngeal cooling 
method.  
 Chapter 3 describes TR-NIRS experiments performed to measure brain 
temperature non-invasively based on the temperature-dependence of the water absorption 
peaks at ~740 and 840nm. The TR-NIRS method was able to measure brain temperature 
  iii 
with a mean difference of 0.5 ± 1.6°C (R
2 
= 0.66) between the TR-NIRS and thermometer 
measurements.  
 Chapter 4 describes the TR-NIR technique developed to measure CBF and 
CMRO2 in a normoxia animal model under different anesthetics at different brain 
temperatures achieved by whole-body cooling. Both CBF and CMRO2 decreased with 
decreasing brain temperature but the ratio CMRO2:CBF (OEF) remained unchanged 
around the normal value of ~33%. These results demonstrate that TR-NIR can be used to 
monitor the oxidative status of the brain in neurological emergencies and its response to 
HT treatment. 
 In summary, this thesis has established a convenient method for selective brain 
cooling without decreasing whole body temperature to levels when adverse effects could 
be triggered. TR-NIRS methods are also developed for monitoring local brain 
temperature to guide SBC treatment and for monitoring the oxidation status of the brain 
as treatment progresses.   
 
Keywords 
Temperature, Hypothermia, Nasopharyngeal cooling, Respiratory cooling, Time-
Resolved Near-infrared Spectroscopy, Cerebral blood flow, Cerebral metabolic rate of 
oxygen, oxygen extraction efficiency, Oxidative Status, Piglets
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Chapter 1 
Introduction 
1.1  Overview 
 The central nervous system (CNS) has a high metabolic rate and depends on a 
continuous blood supply of oxygen and nutrients and clearance of metabolic end-
products. In the event of interruption of circulation, function quickly fails, and if 
circulation is not restored in a short time, irreversible damage to neurons occurs. The 
most common causes of energy crisis are a severe drop in cerebral perfusion or ischemia 
from arterial occlusion due to vasospasm or increased in intracranial pressure from brain 
edema/herniation and a reduction in the oxygen content of blood referred or cerebral 
hypoxia. Cerebral hypoxia refers to a lack of oxygen in the brain, even though blood flow 
and pressure may be normal. It can be caused by many conditions including near-
drowning, strangling, carbon monoxide and other poisonous gas exposures, chocking, 
compression of the trachea, cardiac arrest, diseases which have paralyzed the respiratory 
muscles, and birth asphyxia.  
 Clinical studies have shown that mild (32-35
o
C) and moderate hypothermia 
improves neurological outcome and reduces mortality for a variety of acute brain injuries 
following severe head trauma, cardiac arrest, stroke and neonatal asphyxia. However, 
cooling the whole body below 33-34°C can induce severe complications including 
sclerema, skin erythema, renal failure, coagulopathy, pulmonary hypertension, and even 
death. Such complications along with other ones offset the benefits accrued from the 
neuroprotective effects of hypothermia. In response to the aforementioned complications, 
selective brain cooling (SBC) methods have been proposed to alleviate the complications 
associated with systemic hypothermia by selectively cooling the brain while maintaining 
normal core body temperature. However, SBC requires a non-invasive method that can 
measure local brain temperature, since core measurements may not reflect brain 
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temperature. Improved cooling and monitoring technologies are still necessary to take in 
the full potential of this therapy. 
 The next section of this chapter will introduce neonatal hypoxic-ischemic 
encephalopathy (HIE) and describe the pathophysiology of the brain injury arising from 
and the clinical management of this condition. The chapter will then focus on discussing 
therapeutic hypothermia as the most promising neuroprotectant against hypoxic-ischemic 
(HI) brain injury. The chapter ends with an overview of current techniques to measure 
brain temperature and a discussion of near-infrared spectroscopy (NIRS) and its 
application for measuring tissue temperature and cerebral hemodynamics and 
metabolism. Finally, the objective and scope of the thesis are described to introduce the 
work performed for chapters 2 through 5. 
1.2 Neonatal Hypoxia-Ischemia 
 Neonatal HI is still one of the most important causes of disability and death 
throughout the world.
1
 Approximately four million babies die every year in the neonatal 
period, and one quarter of these deaths are attributed to HI.
2
 HI has an overall incidence 
of 3-5 in 1000 births, and accounts for a large proportion of admissions to neonatal 
intensive care; 10-15% of cases will die in the neonatal unit. Of the survivors, 10-15% 
will develop cerebral palsy and up to 40% will have other significant disabilities.
3
 
Undoubtedly, this clinical event is increasingly becoming a burden not only for the 
patients, but also for the families and communities that care for them. This problem is a 
financial issue as much as it is a health complication. The lifelong projected costs for 
cerebral palsy alone are estimated at $11.5 billion dollars in the United States.
4
 
 HI triggers a cascade of events characterized by a reduction in cerebral blood flow 
(CBF) and oxygen delivery. This phase is referred to as primary energy failure which is 
associated with the reduction in high energy phosphate reserve, loss of membrane ionic 
homostasis, excitotoxicity, an increase in intracellular calcium and the inhibition of 
protein synthesis. Primary energy failure is followed by cell death. Secondary energy 
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failure, which occurs during reperfusion and reoxygenation several hours after the initial 
event and lasts for days. Secondary energy failure initiates a cascade of biochemical 
events, which involve nitric oxide syntheses activation, the production of cytotoxic free-
radicals, inflammation, membrane dysfunction and apoptosis, among others. The time 
interval between primary and secondary energy failure is thought to be a latent phase 
where therapies to reduce brain damage can be applied. This time interval is referred to as 
"therapeutic window".  
1.3 Pathophysiology of HI    
 The principal mechanism underlying neurological damage resulting from HI is the 
deprivation of oxygen supply, which causes a primary energy failure. This energy failure 
forces the cells to generate oxygen independent energy via glycolysis through anaerobic 
respiration, which causes lactate production to increase (acidic bi-product of glycolysis in 
the absence of available oxygen) and creates an acidic environment for the cells in CNS.
5
 
The deleterious effect of this primary energy failure impairs vascular autoregulation (i.e. 
the inability of the cerebral vasculature to maintain adequate CBF during systemic 
hypotension), and the low pH halts the activity of cellular enzymes.
6
 The sodium 
potassium (Na
+
/K
+
) adenosine triphosphate (ATP) pump will then begin to fail, and will 
cause an intracellular accumulation of sodium (Na
+
), chloride (Cl
-
) and calcium ions 
(Ca
2+
).
7
 The intracellular accumulation of these ions will cause the neurons to depolarize 
and release a large amount of excitatory amino acid including glutamate. Glutamatergic 
actions are mediated by two major receptors: N-methyl-D-aspartate (NMDA) and α-
Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). These receptors when 
activated open agonist-operated ion channels, which allow ions to cross the membrane. 
Extracellular glutamate can magnify intracellular concentrations of Ca
2+
 by opening 
NMDA-Ca
2+
 and AMPA- and kainate-Na
+
 channels. Other effects of increased 
intracellular Ca
2+
 include the generation of free-radicals and nitric oxide (NO). As 
reperfusion occurs, glutamate levels return to normal, however; the glutamate receptors 
may remain active as an important cause of brain cell death. 
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 During the reperfusion period, free-radical damage will be initiated and the 
reactive oxygen species (ROS) will combine with the nitric oxide synthase (NOS) from 
glutamate receptor activation to form toxic oxidants.
8
 Furthermore, calcium ion 
accumulation will activate a series of enzymes which lead to oxidative degradation of 
lipids and proteins and DNA damage.
9
 These damaging pathways will initiate the 
apoptotic and necrotic cascade which will cause neurons to die. The releasing of pro-
inflammatory cytokines by resident immune cells of the CNS, and peripheral immune 
cells extravasating to the area of injury will initiate the inflammatory response
10
, all of 
which contribute to cerebral edema, subsequently leading to neuronal death. The 
continuum of neuronal death extends from early which is typically necrotic to delayed 
apoptotic cell death.
11
 Apoptosis occurs over days as a result of a less severe insult, thus 
is a potential therapeutic target.  
1.4 Clinical Management of HI 
 Many potential neuroprotective drugs that target specific pathways of HI brain 
injury have been investigated. These therapies operate at different times after the HI 
insults, depending on their mechanisms of action (Figure 1.1). The main goals of these 
interventions are decreasing the formation of toxic free-radicals to reduce cerebral 
damage, and inhibiting the excessive influx of calcium into neurons to minimize cerebral 
oedema.
12
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Figure 1.1: Neuroprotective therapies and their optimal moment of administration, according to 
their mechanisms of action. 
Figure adapted from Cerio et al.
12
 
 Some interventions that have been investigated in animal and/or human trials 
include: anti-oxidant interventions that could reduce free-radical formation after the HI 
event such as allupurinol, statins, N-acetylcysteine (NAC), melatonin, cannabinoids, 
erythropoietin, deferoxamine and hypothermia.
12
 Apart from producing an antioxidant 
effect, NAC, cannabinoids, melatonin and hypothermia can also modulate the 
inflammatory responses. Furthermore, administration of magnesium sulfate (MgSO4) has 
been shown to be neuroprotective. MgSO4 is an NMDA receptor antagonist, which 
prevents excitotoxic calcium-induced injury through the inhibition of NMDA receptor.
13
 
Moreover, MgSO4 may also have direct actions on mitochondrial activity, have 
anticonvulsant properties and beneficial haemodynamic effects by increasing cerebral 
blood flow.  
 Likewise, the nontoxic anesthetic gas Xenon (Xe) has been shown to be an 
effective neuroprotectant in a variety of neuronal injury models. Xe is a potent NMDA 
antagonist, and has additional mechanisms of action such as inhibition of other subtypes 
of glutamate receptors, reduction of neurotransmitter release, inhibition of 
Ca
2+
/calmodulin-dependent protein kinase II, and protection against excitotoxicity.
14
 
Furthermore, Xe is an attractive adjunct to hypothermia due to its lack of chemical 
reactivity and toxicity, ease of reversibility and rapid brain penetration. It has been shown 
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that neuroprotection significantly increased from ~35% with HT alone to ~70% when HT 
was combined with 50% inhaled Xe gas.
15
 The major disadvantage of this intervention is 
that Xe is very expensive and its administration is rather complicated, since it requires 
intubation and ventilation of the patient as well as a large volume of expensive Xe gas. 
Recently, Dingley et al. have developed a relatively straightforward rebreathing closed 
circuit system suitable for cost effective delivery of Xe to mechanically ventilated 
neonates as a potential neuroprotectant after perinatal asphyxia.
16
  
 Erythropoietin (EPO) has also shown great promise as a neuroprotectant against 
HI brain injury.
17
 It was found to play a variety of roles in the modulation of 
inflammatory responses and has vasogenic effects.
18
 It may activate antioxidant enzymes, 
decrease excitotoxic damage, induce anti-apoptotic and anti-inflammatory factors and 
inhibit lipid peroxidation.
19
 Another neuroprotectant is iminobiotin which has been shown 
to inhibit both nNOS and iNOS in experimental studies.
20
  
 During HI brain injury, neurons, glia and endothelial cells are damaged causing a 
reduction of their functionality or death. Recent advances in regenerative medicine 
suggest that stem cell transplantation may improve repair of the damaged brain.
21
 It has 
been shown that HI induced brain damage can be treated with Mesenchymal stem cells, 
easily recovered from bone marrow, placental tissue, and umbilical cord stroma without 
ethical problems.  
 Compared to the treatments discussed above, hypothermia appears to be a more 
reliable intervention available at the moment for reducing the risk of death or disability 
with brain injury
22
, as discussed in detail in the following section. 
1.4.1 Therapeutic Hypothermia 
 Hypothermia can be classified as mild (32-35°C), moderate (28-32°C), severe 
(20-28°C) and profound at less than 20°C. Clinical studies indicate that the temperature 
range associated with better outcomes appears to be 33-35°C.
23
 Systemic adverse effects 
7 
 
of hypothermia in general appear to be relative to the degree of cooling, occurring at core 
temperatures < 34°C.
24
 The current practice of hypothermia intervention in HI is to 
maintain a cerebral temperature of approximately 33-34°C for about 48-72 h
22
, 
commencing as soon as possible after resuscitation. 
a) Neuroprotective Mechanism 
 Hypothermia is thought to interfere with different damaging cascades, being 
protective both by itself and in prolonging the window for effective application of other 
neuroprotective strategies such as anti-oxidant, anti-apoptotic, or anti-inflammatory drug 
treatments.  
 Research has elucidated two distinct therapeutic windows for clinical use of 
hypothermia. In the early intra-ischemia window, hypothermia modulates abnormal 
cellular free radical production, poor calcium management, and poor pH management. In 
the more delayed post-reperfusion window, hypothermia modulates the downstream 
necrotic, apoptotic, and inflammatory pathways that cause delayed cell death. A 
schematic illustration of these processes is provided in Figure 1.2. 
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Figure 1.2: Schematic illustrating the effects of hypothermia on ischemia/reperfusion injury.   
Figure adapted from Lampe et al.
25
 Post-reperfusion cooling (b) is thought to target only the later cell death 
and inflammatory signaling. Intra-ischemia protection shown in (c) is thought to target both ischemia-
induced cellular abnormalities and post-reperfusion cell signaling. 
 
There are a number of possible mechanisms by which mild hypothermia might improve 
neurological functions which include at least the following: (i) reduction in brain 
metabolic rate, (ii) reduction in free radicals, (iii) blockade of excitotoxic mechanisms, 
(iv) calcium antagonism, (v) preservation of protein synthesis, (vi) modulation of the 
inflammatory response, (vii) apoptosis and mitochondrial dysfunction, (viii) early gene 
activation, and (ix) decrease in edema formation. 
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(i). Reduction in Brain Metabolic Rate 
 It was originally believed that hypothermia’s sole protective benefit was due to its 
ability to reduce cerebral metabolism. For every 1°C reduction in body temperature, there 
is a 6 to 10% decrease in cerebral metabolism.
26
 This temperature dependent decrease in 
metabolism results in a decreased demand for oxygen and glucose in the brain.
27
 The 
reduction in glucose and oxygen consumption helps prevent injury caused by a limited 
supply of oxygen. While there is a decrease in metabolism with hypothermia, we now 
know that this is only one of the many mechanisms of hypothermia. 
(ii). Reduction in Free-Radicals 
 In the section 1.3, the idea that energy failure and consequential increases in 
intracellular Ca
2+
 lead to the production of free radicals was introduced. Free radicals are 
compounds with an uneven number of electrons in the outermost orbital, and as a result, 
are highly reactive. The effects of free radicals are magnified upon reperfusion when free 
radicals can interact with the renewed supply of oxygen to create reactive oxygen species 
(ROS), such as superoxide (O2
-
), which are more destructive. This effect is again 
magnified with the presence of NO, which is also made more abundant by increased 
intracellular Ca
2+
. Superoxide can combine with NO to generate the highly toxic free 
radical species, peroxynitrite (NO2
-
), which is able to rapidly diffuse across cell 
membranes and affect surrounding cells. It also inactivates enzymes including 
mitochondrial ATPase, inhibiting mitochondrial electron transport, which leads to cells 
inability to sustain homeostasis and eventually apoptosis. 
 Under hypothermia condition, the release of free radicals is considerably 
decreased allowing endogenous anti-oxidative mechanisms to prevent or attenuate 
oxidative damage to cells
28
 by prevention of mitochondrial failure, reduction in 
excitotoxicity and neutrophil accumulation, interleukin-1 (IL-1) mRNA upregulation  and 
NOS activity.  
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(iii). Blockade of Excitatory Neurotransmitters 
 The injured tissue releases massive amounts of glutamate which leads to the 
activation of NMDA receptors and concomitant influx of Ca
2+
 into the cell, inducing what 
is known as excitotoxic brain damage. Hypothermia significantly reduces extracellular 
levels of both glutamate and glycine.
28, 29
 Neuroprotective properties of hypothermia may 
be partly due to its ability to prevent increases in the extracellular concentrations of amino 
acids that enhance the activity of the NMDA glutamate receptors and block the sustained 
elevation of the extracellular glycine concentration in response to brain ischemia.
29
 
Glycine is an inhibitory neurotransmitter in the brain stem and spinal cord. The NMDA 
receptor channel cannot be activated in the absence of glycine.
30
 Reducing NMDA 
receptor activation prevents the excessive influx of Ca
2+
 into the cell, thereby preventing 
Ca
2+
-mediated neuronal damage. 
(iv). Hypothermia As a Calcium Antagonist 
 Intracellular calcium concentration is increased when energy fails. Calcium is 
involved in the regulation of many enzyme systems inside the cell such as 
Ca
2+
/calmodulin-dependent protein kinase II, a multifunctional enzyme complex that 
mediates many of calcium’s effects and also regulates protein kinase C which plays a 
pivotal role in neurotransmitter release. Reduced calcium influx might be one of the key 
mechanisms underlying hypothermia-induced neuroprotection. {Sahuquillo, 2007 #613} 
(v). Protein Synthesis Preservation 
 The ubiquitin-proteasome proteolytic system is present in all eukaryotic cells and 
is responsible for the selective degradation of misfolded or damaged proteins. 
Consequently, ubiquitin plays an essential role in maintaining proper cellular functions. 
Ischemia and other brain insults provoke ubiquitin depletion. One consequence of 
ubiquitin deficit is excessive accumulation of abnormal proteins induced by brain injury 
or secondary ischemic events. Hypothermia has been shown to promote ubiquitin 
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recovery in experimental models of ischemia and could be one of the protective 
mechanisms against delayed neuron death.
31
 
(vi). Modulation of the Inflammatory Response 
 In most brain injuries, an inflammatory response begins about 1 hour after 
ischemia-reperfusion and persists for up to 5 days.
32
 Large amounts of pro-inflammatory 
mediators are released inducing inflammatory and immune responses which can cause 
additional-injuries. Hypothermia has been shown to suppress these reactions.
33
 
Interrupting the inflammatory cascade can significantly attenuate the extent of brain 
injury and infarct size. 
(vii). Apoptosis and Mitochondrial Dysfunction  
 Following neuronal injuries such as ischemia, cells may recover, become necrotic, 
or enter a pathway leading to programmed cell death, or apoptosis. Several studies have 
shown that hypothermia can interrupt the early stages of the apoptotic pathway, thereby 
preventing cellular injury from progressing to cell death. Hypothermia appears to reduce 
apoptosis by inhibiting caspase enzyme activation
34
 and preventing mitochondrial 
dysfunction.
35
 
(viii). Early Gene Activation 
 Hypothermia stimulates early gene activation which is part of the protective 
cellular stress response to injury and promotes production of cold shock proteins that can 
be cytoprotective in the presence of ischemic and traumatic injury.
27
  The relatively fast 
induction of the immediate early genes such as fosB, junB and c-jun, following 
hypothermia reflect a faster continuation of normal intracellular signaling, enhancing 
neuronal recovery.
126
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(ix). Decrease in Edema Formation 
 Increased intracranial pressure (ICP) is the leading cause of death after severe 
traumatic brain injury (TBI). This increased ICP reduces cerebral perfusion pressure 
(CPP) and is one of the main causes of brain ischemia. Furthermore, many of the 
secondary injuries progress to dysregulation of intracellular and extracellular water 
content and consequently to brain edema, which both increases ICP and reduces CPP, 
which ends in cell death. Hypothermia decreases the detrimental effects of injury on the 
blood brain barrier and consequently decreases the formation of edema and reduces 
vascular permeability.
36
 
b)  Current Methods of Hypothermia Induction 
 There are two main approaches used to induce hypothermia. The first approach is 
systemic or whole body cooling. The second approach is selective cooling where the 
damaged tissue is cooled, while maintaining the normal core body temperature. 
(i) Whole Body Cooling 
 Systemic cooling induces hypothermia by lowering the core body temperature, 
often by using a blanket to cool the skin surface, which has been a relatively simple and 
popular method. Other whole body cooling approaches include immersing the body into 
cold water, packing the body with ice, or inserting an endovascular cooling catheter. 
Surface cooling cannot always be readily applicable in a clinical setting because of the 
large surface area of the human body and shivering-related complications introduced with 
surface cooling that may be difficult to control.
37
  
 The use of endovascular cooling eliminates complications associated with 
shivering since it directly cools the blood supply while maintaining a normal skin surface 
temperature. A cooling catheter can be inserted quickly, between 10-25 minutes, and the 
target core body temperature, 33-34°C, can be reached more quickly than when 
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hypothermia was induced using a cooling blanket.
38
 However, the major disadvantage of 
this method for systemic cooling is that it requires invasive surgical techniques for 
catheter insertion and success is highly dependent on the skills of the surgeon. 
(ii) Potential Side Effects of Whole-Body Cooling 
 Large decreases in the core body temperature, which are often associated with 
systemic hypothermia, can lead to dangerous complications, such as development of 
sclerema, skin erythema, acrocyanosis, pulmonary hemorrhage, renal failure, increased 
blood viscosity, disseminated intravascular coagulation, hypoglycemia, acid-base and 
electrolyte disturbances, increased risk of infections, significant cardiovascular 
disturbances, and even death.
39, 40
 Sudden cardiac arrest and ventricular tachyarrythmia 
including fibrillation have also been reported in infants who were hypothermic with rectal 
temperatures of less than 34.5°C during exchange transfusion with cold blood. Even mild 
hypothermia of 34-35°C has been reported to cause a marked decrease in myocardial 
contractility
41
, which can lead to conduction disturbances, hypotension and cardiac 
arrhythmia as seen in adults and newborn infants.
42, 43
 Moreover, hypothermia may result 
in decreased leukocyte mobility and phagocytosis, and increased risk of infection, 
especially pneumonia, as reported in adults.
44
  
 A recent study correlating degree of therapeutic hypothermia with fatality and 
physiological disorders reported mortality rates of 39%, 52%, and 80%, respectively with 
mild, moderate, and severe therapeutic hypothermia.
45
 Therefore, in order to avoid the 
complications associated with systemic hypothermia, it may be more beneficial to apply 
selective cooling. This method allows the core body temperature to remain within 36-
37°C while the targeted tissue temperature is reduced. 
(iii) Selective Brain Cooling 
 Methods for selective brain cooling (SBC) include using a cooling helmet, 
epidural cooling, packing the head with ice, forced convection, nasopharyngeal cooling, 
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and directly cooling the blood supplied to the brain. It has been shown that perfusing cold 
saline (4°C) in the epidural space of the brain for 6 hours provided rapid and deep cooling 
to the brain tissue. The brain temperature decreased to ≈ 27-30°C within 5 minutes, while 
the normal core body temperature remained constant.
46
 Using a cooling helmet with 
circulating cold water (4°C) reduced the average brain temperature 2-4°C within 2 
hours
47, 48
, while maintaining normal rectal temperatures. Placing a cooling device 
(≈18°C) on the carotid arteries provided a 2.4°C reduction in the brain temperature of 
rats, while maintaining a constant core body temperature.
49
  
 Nasopharyngeal cooling has the potential to overcome some of the limitations of 
current cooling methods. Based on anatomical features, cooling the nasal cavity may offer 
the capability to cool the brain selectively by cooling blood in both internal carotid 
arteries (ICAs) via counter-current heat exchange mechanism with the neighboring 
cavernous sinuses which collect cold venous blood from the mucosal linings of the nasal 
cavities. Furthermore, cerebrospinal fluid (CSF) chilled at the basal cistern cools the 
whole brain through the CSF circulation. Dohi et al., achieved a lower cooling rate of 
≈2.5°C/h by blowing 24-26°C air at a flow rate of 8-12 L.min-1 directly into the nasal 
cavities of two patients with Foley catheters adjunct with surface cooling.
50
 Furthermore, 
Covaciu et al., demonstrated selective cooling of the brain (≈3°C/h) by circulating cold 
(8-10°C) saline in balloon catheters placed into the nasal cavities of pigs.
51
 A recent study 
employed transnasal evaporative cooling by spraying room temperature perfluorocarbon 
liquid (perfluorohexane, PFH; F2 Chemicals) into the nasal cavities with compressed 
oxygen to achieve average intra-nasal cooling rate of ≈4°C/h.52 However, use of 
perfluorocarbon raises environmental and health issues. It is a greenhouse gas and 
depletes the ozone layer and is listed as a toxic substance under the Canadian 
Environmental Protection Act (CEPA).
53
 Another safety concern is the risk of coolant 
aspiration which might cause lung damage over prolonged periods since neural protection 
therapy may involve mild hypothermia being maintained for 72 hours. 
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c)  Rewarming 
 Rewarming is a delicate phase of therapeutic hypothermia. Adverse consequences 
of whole body rewarming may lead to secondary injury seriously limiting the protective 
effects of hypothermia. Many studies demonstrated that a slow rewarming rate (0.1-
0.4°C/hr
54
) improves clinical outcome, while rapid rewarming may impair 
thermoregulation and exacerbate cell damage
55
, and have unfavorable effects on basic 
hemodynamic variables.
56
 Significant decreases in jugular venous oxygen saturation have 
been reported during rapid rewarming of patients following cardiac surgery under 
hypothermic conditions, indicating hypoxia of the brain
57
; more slow rewarming led to a 
decrease in the incidence and severity of jugular bulb desaturations. Rapid rewarming 
was also recognized to cause a rebound in intracranial pressure
58
, as well as cause a 
mismatch between increases of cerebral metabolic rate of oxygen (CMRO2) and cerebral 
blood flow.
59
 Rapid rewarming may open the permeability transition pore in the 
mitochondrial membrane, and hence result in mitochondrial dysfunction.
60
 Following the 
rewarming phase, another important concept is the maintenance of strict normothermia, 
as fever is independently linked to adverse outcome in all types of neurological injuries. 
In summary, optimal cooling duration and cooling depth still remain inconsistent and 
require further investigations. The general agreements among clinicians are early cooling 
initiation within the treatment window after injury and gradual rewarming. These 
approaches usually yield maximum neuroprotection and avoid adverse effects.  
1.5 Current Methods of Brain Temperature 
Measurement 
 Once the brain is damaged, whether by brain ischemia or physical injury, brain 
temperature rises above body temperature. A typical elevation is between 1°C and 2°C.61, 62 
As a result, core body temperature is not reflective of the actual brain temperature or the 
efficiency of therapeutic management; therefore, having a method to measure brain 
temperature non-invasively is extremely useful and important during hypothermia 
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treatment. Moreover, SBC requires a method that can measure local brain temperature rather 
than body temperature as the latter may not reflect the actual brain temperature. Several 
approaches have been developed to assess brain temperature. Brain temperature can be 
measured using infrared tympanic thermometer, zero-heat-flux thermometry, microwave 
radiometry, magnetic resonance spectroscopy, and ultra-sound thermometry. 
1.5.1 Tympanic Membrane Thermometry 
 The tympanic membrane (TM) is the boundary between the outer and middle ears, 
commonly known as the eardrum and its location is proximal to the internal carotid (ICA) 
artery; therefore, tympanic membrane temperature should be the same as that of blood in 
the ICA supplying the brain. However, in recent publications, TM temperature was 
shown to differ from brain temperature by as much as 2.5-3°C.
63, 64
 Such differences 
might be attributable to poor thermal insulation of the measuring probe from the 
surrounding ear canal and poor contact between the probe and the membrane itself. If the 
sensor is not correctly positioned it may detect infra-red radiation energy emitted from the 
ear canal rather than that of the tympanum. 
 
Figure 1.3: Tympanic thermometer.
65
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1.5.2 Zero-Heat-Flow Method 
 Zero-heat-flux (ZHF) method is another technique to measure tissue temperature 
by inducing an isothermal zone under the sensor by heating the skin surface in a way that 
the outward heat flow from the core is matched with inward heat flow from the surface.
66
 
The ZHF probe actively heats the tissue until no temperature gradient exists across the 
probe. When an equilibrium is reached there is a region of tissue below the surface which 
has a uniform temperature. The thermometer probe consists of two temperature sensors 
separated by an insulating pad, which also houses a heating element. One of the sensors is 
in contact with the patient’s forehead and the other one faces away from the forehead. A 
surface heating element is placed on top, along with another layer of insulation, switching 
on or off depending on the direction of the temperature gradient between the two sensors. 
The temperature on both sides of the layer is continuously monitored; when the sensors 
eventually reach the same temperature, no additional heat can flow out through the pad 
and the deep body temperature is inferred by the temperature of the skin sensor. 
 
Figure 1.4: Principle of the zero-heat-flux (ZHF) method.  
Figure adapted from Dittmar et al.
67
 
Recently, it has been shown that ZHF method accurately reflects core temperature during 
mild hypothermia in patients after cardiac arrest with accuracy of ∼ ±0.5°C compared to 
core temperature.
68, 69
 A potentially serious problem is the possibility of inducing an 
increase in brain temperature during its operation in hypothermia treatment.
70
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1.5.3 Magnetic Resonance Thermometry 
 The application of magnetic resonance (MR) to noninvasive thermometry of 
biological tissues is based on the effects of temperature on proton density, relaxation 
times T1 and T2, the water diffusion coefficient and the water proton resonance frequency 
(PRF).
71
 Among these parameters, the chemical shift of the water proton has been 
recognized as the most reliable and practical indicator of temperature.
72
 Three methods, 
phase mapping, single-voxel spectroscopy and spectroscopic imaging (SI), have been 
proposed for measurement of temperature using proton chemical shift.  
 In phase-difference PRF thermometry, phase maps acquired before 
heating/cooling (referred to as the baseline phase maps) are subtracted from phase maps 
measured after treatment. Temperature differences are calculated based on phase 
variations with respect to a reference baseline.
73
 Since there is a temporal delay between 
the current and the baseline acquisition, this method is very sensitive to motion artifacts. 
However, referenceless phase-difference methods
74
 were proposed to remove motion 
artifacts by assuming that the thermal changes are localized to a small and well defined 
area. The method requires prior knowledge of where the temperature change will occur. 
Obviously, these assumptions are not applicable in the case of global brain cooling. The 
second group of PRF techniques uses magnetic resonance spectroscopy (MRS) or 
magnetic resonance spectroscopic imaging (MRSI) acquisitions to measure changes in 
water spectral line position. Motion and magnetic susceptibility artifacts can be reduced 
using an internal temperature-independent metabolite resonance. N-acetylaspartate 
spectral line at ~2 ppm is most often used for the brain. However, the long measurement 
time (typically in the order of a several minutes) and poor spatial resolution limit its 
application, even when applying a fast technique such as echo-planar spectroscopic 
imaging. Weis et al have recently compared two magnetic resonance methods, phase-
difference and MRSI methods with high spatial resolution, for monitoring brain 
temperature changes during cooling on ten healthy volunteers. Mean brain temperature 
reduction varied in the interval 0.6-3.0°C and 0.7-2.7°C as measured by the MRSI and 
phase-difference methods, respectively.
73
 The main advantage of the phase-difference 
technique is its simplicity and rapid measurement acquisition time. The disadvantage lies 
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with the phase wrapping that can complicate measurements in the areas containing fat 
tissue or in those regions with increased magnetic field inhomogeneity. The MRSI 
technique avoids the phase-wrapping problem and is able to separate water and fat signals 
for temperature measurement in tissues that contain fat. However, the disadvantage of this 
technique lies with the prolonged measurement acquisition time, more complicated data 
processing and the need to transfer patients to imaging facilities.
73
 
1.5.4 Microwave Radiometry 
 Microwave radiometry (MWR) technique use the tissue temperature-dependence 
of the power of the natural blackbody thermal radiation emitted from body tissues.
75
 
Lossy dielectric materials such as human body tissues are partially transparent to 
microwave radiation in the frequency range from 1-4 GHz allowing the measurement of 
temperature at a significant depth within the body.
76
 For brain tissue, the effective depth 
is tens of millimeters and changes with frequency. By measuring temperatures in several 
microwave frequency bands, the internal temperature profile can be estimated from the 
data by solving an inverse problem. Han et al., have developed a five-band microwave 
radiometer to measure the brain temperature of infants during hypothermia therapy 
demonstrating an accuracy of ±0.75°C.
77
 There are several issues in the application of 
MWR to the measurement of deep brain temperature. These problems include relatively 
poor temporal and spatial resolution of the measurements and systemic errors arising 
from inaccuracies in model parameters.
78
  
1.5.5 Ultrasound Thermometry  
 Ultrasound is an attractive modality for temperature monitoring because it is 
inexpensive and has relatively simple signal processing requirements. This modality may 
be useful for temperature estimation if a temperature-dependent ultrasonic parameter can 
be identified, measured and calibrated. The use of echo shifts has received the most 
attention in the last decade. It has been shown that by measuring the time shift of received 
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echoes and tracking scattering volumes, the temperature from a region of interest can be 
predicted. However, prior knowledge of both the speed of sound and thermal expansion 
coefficients are necessary, which limits this technique for temperature measurement.
79
 
Moreover, acoustic attenuation is also dependent on temperature, but with significant 
changes occurring only at temperatures above 50°C.
80
 Minimal change in attenuation 
below this temperature range reduces its attractiveness for use in clinical applications. 
The major disadvantage of this technique is inducing temperature increase, which limits 
the protective effects of hypothermia. Fater et al. demonstrate a good correlation of tissue 
heating and transcranially transmitted ultrasound of mid-kilohertz range (340 kHz). They 
showed that brain temperature increased within 2 to 5 minutes of insonation with average 
elevation of 0.9°C with 7 W/cm
2
.
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1.6 Near-Infrared Spectroscopy  
 Optical methods are a promising alternative to the aforementioned techniques 
since they are safe and the instruments are compact and portable. Biological tissue is 
relatively transparent to NIR (650-100 nm) light due to the low optical absorption 
coefficient in this region. The major absorbing chromophores in the NIR include water 
(H2O) and oxy- (HbO2) and deoxyhaemoglobin (Hb). Figure 1.5 displays the specific 
absorption spectra of H2O, HbO2 and Hb in the NIR range.  
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Figure 1.5: Specific absorption spectra of H2O, Hb, and HbO2 in the NIR range. Values for H2O are 
adjusted by a factor of 10, for illustrative purposes. Extinction coefficients of pure water and oxy- 
and deoxy-hemoglobin were taken from literature.
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1.6.1 Optical Characteristics of Tissue  
 Biological tissues are comprised of a vast assortment of molecules organized in 
different structures and functional units. There are four independent macroscopic 
parameters that are believed to characterize light propagation in tissue: the index of 
refraction (n), the absorption coefficient (μa), the scattering coefficient (μs), and the 
scattering anisotropy (g).  
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1.6.2 Light Scattering in Tissue 
 The ability to perform quantitative spectroscopy is complicated by the high-scatter 
nature of tissue. Scattering can be defined as the dispersion and redirection of wavelets in 
the medium of transmission. Scattering and light redirection can occur when light is 
incident on small particles (Rayleigh scatter), larger structures (Mie scatter), and at 
interfaces between media of differing indices of refraction (Fresnel reflection). As light 
propagates through tissue, it interacts with cell membranes, tissue boundaries, and 
organelles; at each interface, light is reflected and refracted by these objects, and 
therefore experiences a deviation in trajectory. When NIR light is used to interrogate 
biological tissue, all three major modes of light redirection can occur multiply and in 
combination. In fact, scattering events far outnumber absorption events, where the main 
light scattering components of cerebral tissue are lipoproteins found in cell membranes, 
followed by mitochondria and other cellular components.
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The definition of mean free path (MFP) is the mean distance that a photon travels in the 
medium of tissue before it is absorbed, (absorption MFP: la) or scattered (scattering MFP: 
ls). The reciprocal of a MFP is the corresponding of absorption or scattering coefficient ( 
μa = 1 / la, and μs = 1 / ls).  
The anisotropy factor g is defined as: 
             
 
 
             (1-1) 
where      
 
 
              , and      is the distribution pattern of possible 
deflection angles of a photon scattered by a particle. These optical parameters should 
provide some information about the biomedical properties as well as the morphological 
and structural configurations of tissue. The reduced scattering coefficient μs′ is then 
defined as: 
            (1-2) 
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The purpose of     is to describe the diffusion of photons in a random walk of step size of 
1/    where each step involves isotropic scattering. It follows that the transport 
attenuation coefficient is the sum of both absorption and reduced scattering coefficients:  
       
 
 . In NIR range, since  
 
    , it is usually assumed that     
 
 . In 
addition, the wavelength dependence of     is well approximated by the so called power 
law: 
         
    (1-3)   
 
where A and b are constants either empirically determined or predicted by Mie theory, 
depending on the application.
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1.6.3 Light Absorption in Tissue 
 The absorption coefficient (μa) describes the effectiveness of light absorption by a 
chromophore. When light radiation is incident on matter composed of discrete electrical 
charges, the charges are forced to oscillate at the frequency of the incident electric field. 
When infrared radiation is incident on a system of matter, resonance will occur, whereby 
energy is transferred from the incident field to the system and its amplitude of vibration is 
greatly increased. The excited state of the atoms or molecules usually lose their energy by 
colliding with one another within 10
-12 
seconds, thereby raising the kinetic energy of the 
other particles involved in the collisions. Hence, the energy associated with the incident 
field is most often dissipated as heat within the medium. This process is known as 
absorption. 
The overall effect of absorption is a reduction in the intensity of the light beam travelling 
the medium. A relationship between the absorption of light in a purely absorbing medium 
and the thickness of the medium was first determined as the Beer-Lambert law  
.. .
0 0
a LC LI I e I e
   in base of e or                                                             
. .
010
C LI I  in base on 10 
(1-4) 
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where I0 is the incident intensity, I is the transmitted intensity, (the log ratio of which is 
the attenuation of light), C is the chromophore concentration, L is the path length of light 
through the medium, and α and ε is known as the specific absorption coefficient for base 
of e and 10, respectively. The ability to perform spectroscopy in-vivo relies on the fact 
that there are few absorbers of NIR light in biological tissue allowing adequate light 
penetration of the tissue. The chief endogenous absorbers are water, oxygenated 
hemoglobin, deoxygenated hemoglobin and lipids. 
a) Water 
 The average water content of neonatal brain is estimated to be 85 % of the mass of 
the brain and 80 % of the adult brain.
85
 Because of its high concentration in most 
biological tissues, water is considered to be one of the most important chromophores in 
tissue spectroscopy measurements. The extinction coefficient for water shows a general 
trend of increase with increasing wavelength. Between 600 and 900 nm there exists a 
region of relatively low absorption. Within this NIR range (600-900 nm), water has two 
distinct features in its absorption spectrum: one at 740 nm and another at 840 nm. Above 
900 nm the absorption coefficient increases fairly rapidly to a peak at about 970 nm. In 
fact, for wavelengths of light greater than 900 nm, absorption by water is strong enough 
to limit the propagation of light to less than 1 centimeter, effectively forming the upper-
limit on what is termed the "optical window" of NIR. Within tissue, water binds to a 
variety of molecules such as other water molecules, proteins (collagen, myosin, actin), 
mineral deposits in bone and phospholipids bilayers. The hydrogen bonding with these 
molecules changes the NIR spectral features derived from O-H vibrations. 
b) Hemoglobin 
 Hemoglobin is the strongest endogenous absorber of NIR light. Hemoglobin is a 
large iron-containing protein found only in the blood, and constitutes approximately 40-
45% of the whole blood. It is responsible for delivering oxygen from the lungs to body 
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tissues and returning waste gases, such as carbon dioxide, to the lungs to be exhaled. 
Carbon dioxide is transported in the blood from the tissue to the lungs by one of three 
methods
86
: (i) About 5-7% is dissolved directly into the blood (ii) 10% binding to 
proteins, particularly haemoglobin; and (iii) 85% carried as a bicarbonate ion. Both Hb 
and HbO2 exhibit strong absorptions at wavelengths shorter than 600 nm: effectively 
placing a lower-limit constraint on the range of wavelengths suitable for tissue 
interrogation. Another feature to note is the isosbestic point where the specific extinction 
coefficients of these two forms of hemoglobin are the same. Within the NIR range, the 
specific absorption spectra of Hb and HbO2 cross at 800 nm but the marked differences 
between them at other NIR wavelengths have allowed the determination of tissue blood 
oxygenation with NIRS. The temperature-dependent changes of the hemoglobin NIR 
absorption spectra have been investigated
87, 88
. It has been shown that by increasing the 
temperature in the range of 20-40°C, the amplitude of Hb and HbO2 decreased by 0.15-
0.18% °C
-1
 and less than 0.05% °C
-1
 and shifted by 0.08 nm °C
-1
 (red-shifted for 760nm) 
and 0.15 nm °C
-1
, respectively.
87
 The amplitude changes in Hb are likely to have more 
significant effect on the total absorption in the range of interest than those for HbO2.  
c) Lipids and Other Absorbing Compounds  
 Lipids constitute about 5% of the total wet weight of a newborn infant’s brain. 
This percentage increases to 8% of the grey matter and 17% of the white matter in 
adulthood. The specific absorption of NIR light by lipids is similar in magnitude to that of 
water. Lipid will not significantly add to the overall extinction coefficient of brain tissue 
as it is only present at approximately one tenth the proportion compared to water. Other 
negligible absorbers include some other enzymes involved in cellular respiration and 
some proteins found in blood plasma, none of which are abundant enough to contribute 
significantly to in-vivo spectroscopy. 
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1.6.4 in-vivo spectroscopy 
 The aim of NIR spectroscopy is to quantify the concentrations of these 
chromophores in tissue, and this requires the ability to separate the effects of absorption 
from those of scattering. Fundamentally, the coefficients of absorption (μa) and reduced 
scattering       can be determined by a series of reflectance measurements performed in 
one of three domains, namely, time
89
 (with a fast pulse of light), frequency
90
 (with a 
sinusoidal modulated source of light), and steady state or continuous wave (CW)
91
 (with a 
source of constant intensity). These three techniques are illustrated schematically in 
Figure 1.6.   
 
Figure 1.6: Schematic illustration of the three main types of NIRS instrumentation. 
Figure adapted from Delpy et al.
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Associated with each type of instrumentation is an equally wide range of types of 
measurements that can be made with them. Quantitative NIRS of the brain can essentially 
be separated into four subfields: spatially resolved spectroscopy, second derivative NIRS, 
frequency-domain and time-resolved spectroscopy. For a complete review of these 
techniques see Delpy et al.
92
 In spatially resolved spectroscopy simultaneous 
measurements of attenuation at multiple distances are combined to obtain sufficient 
information, to separate absorbance and scattering properties at spatially resolved 
locations.
93
 Derivative of light attenuation with respect to optode spacing can be used to 
derive the product of the optical properties, i.e., μa        . If the wavelength dependence 
of the reduced scattering coefficient is known for the tissue of interest then the absorption 
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coefficient can be calculated and presumably used to calculate absolute concentrations of 
chromophores.  
 Second derivative spectroscopy technique can estimate chromophore 
concentrations from an attenuation spectrum, by approximating a linear relationship 
between the measured attenuation and absorption of the medium. The dominant term in 
the second-order derivative of attenuation spectrum with respect to wavelength is the 
product of the differential pathlength, and the second derivative of the chromophore 
absorption spectra. Regressing the derivative chromophore spectra on to the derivative 
attenuation spectrum will yield the product of pathlength, and concentration for each 
chromophore. Concentrations of chromophores can be evaluated based on two 
assumptions: that the water concentration of the tissue of interest is constant and the 
tissue is homogeneous.
94
   
 Frequency-domain (FD) techniques modulate the intensity of a light source at 
radio frequencies to produce the diffuse photon density wave that propagates through the 
tissue.
95
 The phase and amplitude of this wave are measured at the detector which allows 
calculation of the optical pathlength and enables conversion of changes in attenuation to 
changes in absorber concentrations. Time-resolved NIR methods are photon counting 
techniques that use a laser light source to emit pulses of monochromatic light and fast 
detectors to measure the time-of-flight of each detected photon (i.e., the time required for 
a photon to travel from the laser to the photomultiplier tube). This process is repeated, 
typically at a frequency of around 80 MHz until about 10
7
 photons are measured, and 
temporal point spread function (TPSF) is generated. Furthermore, by fitting the TPSF to 
an appropriate model of light transport, values for both the absorption and reduced 
scattering coefficients can be estimated and absolute concentrations of absorbers can be 
calculated. Time-resolved spectroscopy was the technique of choice for the work 
completed in this thesis. This section will be followed by reviewing the previous studies 
which have utilized NIRS to measure temperature. 
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1.6.5 Temperature Monitoring by Near-Infrared Spectroscopy 
 There are a number of studies that have investigated the temperature dependent 
effects on tissue water NIR spectra. As pure water is heated the fraction of hydrogen 
bonds are reduced through thermal agitation of the water molecules, which overcomes the 
force of the hydrogen bonds. This in turn produces a blue-shift of the water absorption 
peak. The water NIR absorption peaks around 740, 840 and 970 nm decreases in 
amplitude by approximately 0.5-0.8%°C
-1
, and shifts towards higher wavelengths with 
decreasing temperature; an approximate shift of 5-10 nm (easiest to see in the 970 nm 
band) has been reported over the range 30-40°C.
96
 Water absorption spectra as a function 
of temperature are shown in Figure 1.7. These temperature dependent spectral shifts are 
due to decreases in the extent of intermolecular hydrogen bonding by water molecules 
with increasing temperature. 
 Hollis et al. investigated the use of an optical technique to measure tissue 
temperature. They used a broadband CW technique to measure reflectance over the 
spectral range of 650-980 nm. Within this spectral window water absorption peaks are 
located at ~740, ~840 and ~976 nm. The primary focus of their work was on the 
absorption peaks at 740 and 840 nm because the lower absorption of these peaks relative 
to the 976 nm peak allows for deeper penetration of light. They used the technique of 
principal component regression (PCR) to calibrate the temperature response of pure water 
spectra in order to determine dominant spectral features associated with temperature 
changes that could then be used for fitting the tissue temperature. Measurements 
performed on an adult forearm had a standard error of prediction of ~1.2°C for the 
recovered temperature. Hollis concluded that in order to improve results scattering should 
be accounted for and that using the water peak at ~976 nm would provide more contrast 
although it would limit the light penetration depth in the tissue.
96
 Chung et al. have also 
demonstrated a method that employs broadband diffuse optical spectroscopy (DOS) to 
measure tissue temperature based on resolving water vibration frequency shifts in NIR 
water absorption spectra that occur with changes in temperature and macromolecular 
binding state. DOS acquires scattering-separated absorption spectra, typically from 650 to 
1000 nm, using a combination of frequency domain and steady-state reflectance and 
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provides an absolute measure of absorption, unlike conventional reflectance methods. The 
method focuses on the ~976 nm water peak for greater contrast in temperature and uses 
the temperature isobestic point at 996nm, in which the specific absorption spectra of 
water at different temperature is constant, to separate the macromolecular bound water 
contribution from the thermally induced spectral shift which requires quantifying subtle 
changes in the NIR water absorption features and a high-resolution calibrated 
spectrometer. This method has been tested in tissue simulating intralipid phantoms. The 
average difference between optical and thermistor measurements was ~1.1 ± 0.91°C in 
the temperature range of 28-48°C.
97, 98
  
 
Figure 1.7: NIR absorption spectra of pure water at various temperatures. Extinction coefficients of 
pure water as function of temperature were taken from literature.
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1.7 Cerebral Blood Flow and Cerebral Metabolic Rate 
of Oxygen 
 As discussed in detail in the section 1.4.1, one of the important mechanism of HT-
induced neuroprotection is the preservation of brain ATP levels resulting from a reduction 
in cerebral metabolism or metabolic rate of oxygen (i.e. CMRO2).
99
 The effects of HT on 
CBF are a consequence of the well-accepted phenomenon that CMRO2 is closely coupled 
to CBF and therefore, a reduction in the former is coupled to a reduction in the latter.
100, 
101
 Preserving the coupling between CBF and CMRO2 is an important factor in the control 
of the cerebral circulation, connecting the change in metabolic demands with the supply 
of substrates by blood flow. As a consequence of this balance between flow and 
metabolism, the oxygen extraction fraction (OEF) indicates any regional variation in 
brain. As such, it is critical to measure these key physiological parameters throughout 
therapeutic hypothermia, particularly during rewarming phase. Rapid rewarming of the 
injured brain commonly leads to a mismatch between cerebral metabolism and 
perfusion
59
 and can cause in rebound intracranial pressure elevations
58
, cerebral venous 
desaturation
102
, and brain ischemia. It is suggested that controlling the rewarming rate as 
low as 0.1-0.4°C/hour is preferred to reduce the neurological risks.
54
 Therefore, 
predicting and managing possible systemic side effects of rewarming is also important for 
guaranteeing HT efficacy. 
1.7.1 Current Techniques 
 CBF can be defined as the blood volume travelling through a given amount of 
brain tissue in a given amount of time. All methodologies require the use of a tracer, 
whether introduced or endogenous, diffusible or intravascular with the various imaging 
modalities that include positron emission tomography (PET), Xe-enhanced computed 
tomography (XeCT), perfusion CT (PCT), and magnetic resonance imaging (MRI). 
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 PET is diagnostic tool that provides quantitative information on a variety of 
hemodynamic parameters such as CBF, cerebral blood volume (CBV), OEF and glucose 
metabolism. PET has evolved to be considered the gold standard for studying cerebral 
hemodynamics. Tracers are being used for CBF measurements are 
15
O2, C
15
O2 and 
H2
15
O.
103
 The other tracer is 
18
F in fluorodeoxyglucose which is used to monitor glucose 
consumption in cancer evaluation.
104
 Data acquisition takes typically 5-10 minutes and it 
takes another 5-10 minutes to obtain a processed CBF map. The main advantage of PET 
is the accuracy and reproducibility of its results. However, PET imaging involves the 
injection of radioactive tracers, which limits its repeatability and application in healthy 
volunteers. Among other limitations are low temporal and spatial resolution, low signal-
to-noise ratio (SNR), as well as the requirement for a cyclotron. PET allows 
quantification of CBF by measuring either the delivery or clearance of radioactively 
labeled water. To measure the delivery of the agent with PET, 
15
O-labeled water is 
injected into the subject's blood stream and emission data is acquired. To measure agent 
clearance, the subject breathes 
15
O-labeled CO2. When CO2 is absorbed in the blood, the 
15
O exchanges with oxygen of water, and this 
15
O-labeled water perfuse the brain tissue. 
Upon cessation of the CO2 inhalation, the clearance of the agent is measured several 
minutes. Tracer clearance occurs by radioactive decay of the labeled water and physical 
clearance by means of the local blood flow.  
 XeCT is a diffusible tracer technique that provides quantitative CBF by 
administering Xe via inhalation and using the time-dependent concentration of Xe in 
tissue as a measure of perfusion. After Xe is inhaled, it crosses the blood-brain barrier and 
diffuses into cerebral tissue.
105
 CBF is then measured by determining the Xe clearance 
rate from the brain using the Kety-Schmidt model
106
, which describes the relationship of 
CBF to the tracer blood/brain partition coefficient and tracer concentration in the brain 
and arterial blood. Because XeCT requires specialized equipment, is expensive, and 
necessitates that an anesthetist be present during the procedure
107
, perfusion CT (PCT) is 
more often used clinically. 
 PCT measurements depend on the injection rate and cardiac output
108
 and have 
proven to be clinically useful for analysis of CBF, CBV, and mean transit time.
109
 When 
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combined with acetazolamide, perfusion CT can yield analysis of the cerebral vascular 
reserve (CVR), thus enabling an extensive evaluation of cerebral hemodynamics.
110
 PCT 
can accurately give a quantitative index of CBF that is comparable with the gold standard, 
PET. Compared with PET, PCT provides for shorter examination times
111
, offers higher 
spatial resolution
103
, and provides a simple acquisition.  
 The two types of MRI measurement of blood flow are arterial spin labeling (ASL) 
MRI
112
 and dynamic susceptibility contrast (DSC) MRI
113
. In DSC imaging a 
paramagnetic material such as gadolinium-DTPA produces dephasing in a small area 
around the tracer in its first pass and as it moves in vessels it affects the T2* in adjoining 
tissues. Perfusion can be measured based on the change in the MR signal. To measure 
absolute quantitative values, the arterial input function (AIF) is required. AIF is the 
concentration-time curve of the tracer in the artery supplying the tissue. The technique 
requires fast imaging sequences such as echo planar imaging (EPI). Images are taken in 
the rate of 500 ms to 2 seconds per single image. The major drawback to produce 
quantifiable data is the lack of robust arterial input and venous output functions. The 
difficulties with obtaining robust measurements of arterial or venous curves in perfusion 
MRI relate back to the problems of signal-to-noise, image contrast, spatial resolution. 
ASL uses water as an endogenous diffusible tracer. In this technique, arterial blood water 
protons are labeled proximal to the region of interest by applying radiofrequency pulses 
to invert the spins. The labeled water then travels throughout the vasculature into the 
capillary bed, where it exchanges with tissue water. Thus the tissue water is partially 
saturated when the voxel is imaged, causing a reduction in the signal intensity 
proportional to the amount of labeled water in that voxel. By subtracting the labeled 
image from a control image, in which there is no labeling of water spins, the relative CBF 
can be determined for each voxel in the imaging plane. The difference between labeled 
and control acquisitions is about 1% of the control signal intensity. The method suffers 
from low signal to noise ratio. 
 Bedside techniques for monitoring CBF include transcranial Doppler (TCD) 
ultrasonography
114
, and thermal diffusion
115
 and laser Doppler flowmetries.
116
 However, 
TCD ultrasonography is used for global CBF investigation and limited to observations of 
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large vessel flow velocities, which do not necessarily reflect microvascular perfusion in 
patients with cerebrovascular disease
117
, and both thermal diffusion and laser Doppler 
flowmetries are invasive. Furthermore, one technique that is commonly used in animal 
studies makes use of microspheres. Microspheres are small polymer or ceramic beads, 
typically labeled with radioactive material, which are injected into the blood stream. By 
creating microspheres that are smaller than the diameter of arterioles, but larger than the 
capillary diameter, the microspheres become trapped in the capillary bed. In animal 
models, the tissue can be sectioned, and the detected radioactivity from each tissue 
section is proportional to the CBF.  
 Optical methods are promising alternatives to these current techniques since they 
are safe, the instruments are compact, portable and can provide physiological 
measurements at the bedside of patients. The methods employed for measuring CBF and 
CMRO2 in this thesis rely on the administration of a non-diffusible, intravascular tracer. 
Consequently a review of the theory behind this technique is warranted. 
1.7.2 Cerebral Blood Flow Measurement by NIRS 
 The NIRS technique presented in this thesis to measure hemodynamic information 
rely on a bolus injection of a contrast agent. The transport of the tracer through the 
microvasculature of the tissue can be described by constructing a kinetic model and 
applying it to time-dependent measurements of the tracer concentration. For example, 
blood flow in brain, CBF, can be calculated using an intravascular tracer if the time-
dependent concentration of tracer in the brain, Q(t), in the arterial and the venous blood 
draining the brain, Ca(t) and Cv(t), are measured. In this case, the following expression 
describes the dynamic behaviour of the tracer 
                      
 
 
          
 
 
   (1-5) 
where t represents a dummy time variable to integrate over. Application of equation (1-5) 
for calculation of CBF is hindered by difficulties associated with measuring Cv(t). Tissue 
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vascular bed can be considered as a mesh of microvessels supplied by a single input and 
draining to a single output, where each possible path from the artery to the vein has a 
specific transit time (amount of time required for tracer to travel from input to output in 
the tissue region of interest (ROI)). In this case, the concentration of tracer in the tissue at 
a given time point is a function of its collective path through the capillary bed, as well as 
the arterial input function. By definition, h(t) is the distribution of transit times of the 
system. Based on this theory, the venous output can be represented as follows: 
                     
 
 
  (1-6) 
where u is a dummy variable in the convolution. Equation of (1-5) can be rearranged as 
follows: 
      
  
                        (1-7) 
where * represents the convolution operator. The impulsed residue function, R(t), can be 
defined as follows: 
               
 
 
 (1-8) 
 and is the proportion of tracer in the system as a function of time when an impulse 
function is the input. Substituting R(t) for h(t), equation (1-7) can be rewritten: 
                      (1-9) 
Q(t) and Ca(t) are the amount of ICG in the brain and arterial blood, respectively, and 
[CBF.R(t)] is the flow-scaled impulse residue function or R(t). The function CBF·R(t) can 
be extracted from the arterial and tissue contrast concentration curves using a 
deconvolution algorithm.
118
 The initial height of the derived function is CBF, since by 
definition R(0)=1, and the area under the curve is the cerebral blood volume (CBV).
119
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1.7.3 Cerebral Metabolic Rate of Oxygen Measurement by 
NIRS 
 Measurements of CMRO2 were calculated
120
 using Fick's principle as follows: 
                        (1-10) 
The difference between the arterial concentration of oxygen, [O2]a, and the cerebral 
venous concentration of oxygen, [O2]v, is commonly referred to as the arterial-venous 
difference of oxygen (AVDO2), or the difference between the O2 concentration of the 
arterial blood feeding the tissue of interest and O2 concentration of the venous blood 
draining the tissue of interest. Equation (1-10) can be further expanded as follows
121
: 
                                 (1-11) 
where     ] is total hemoglobin concentration which can be measured from arterial 
blood samples.               are arterial and venous O2 saturation, respectively. The 
constant 1.39 is the O2 carrying capacity of hemoglobin measured in milliliters per gram 
of Hb. Note that the dye densitometer also provides continuous measurements of     , 
while      was determined indirectly from the NIRS measurements of average tissue 
cerebral blood oxygen saturation,            . This technique relies on the assumption 
that there exists a stable arterial-venous blood ratio in the CBV, i.e. 
                            (1-12) 
where   represents the fraction of arterial blood in CBV. The relative distribution of 
arterial and venous compartments is generally accepted to be approximately 25% and 
75% in the total CBV, therefore to measure          was set to 0.25.
122, 123
 To obtain 
tissue cerebral blood oxygen saturation, i.e.,            , cerebral hemoglobin (HbO2, 
Hb) concentrations can be calculated with the NIRS technique.             can then be 
calculated as follows: 
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   (1-13) 
Using this relationship, a new expression for       can be derived that is independent 
of     : 
                       
                 
   
   (1-14) 
The fraction of oxygen extracted from arterial blood into the brain, OEF, can be 
calculated with the method described by Brown et al
120
: 
    
     
         
   (1-15) 
The tight coupling of CBF and CMRO2 in the normal brain leads to a fixed level of OEF 
around ~33%.
124
 A decoupling of the two, signifies oxidative stress, as in ischemia, and 
would lead to an increase in OEF beyond the normal value of ~33%.
125
 
1.8 Thesis objectives 
The objectives of the work presented in this thesis are to develop a neuroprotection 
method for neurological emergencies by inducing brain hypothermia quickly and 
selectively to avoid adverse complications from whole body cooling and NIRS methods 
for monitoring the brain temperature and neuroprotective effects of hypothermia during 
cooling. 
This work comprised of the following projects whose goals are to 
(i). Develop an effective, safe, simple and fast nasopharyngeal cooling method to 
selectively reduce and maintain brain temperature in the range of mild hypothermia 
(32-35
o
C) while maintaining the whole body (rectal) temperature above 35
o
C. 
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(ii). Develop a TR-NIR technique to measure local brain temperature which can be used 
at the bedside of patients. 
(iii). Evaluate the utility of TR-NIR for measuring cerebral blood flow (CBF) and 
cerebral metabolic rate of oxygen (CMRO2) and in particular their ratio oxygen 
extraction efficiency (OEF) as a surrogate marker of oxidation status of the brain 
during hypothermia and investigates the effects of different anesthetic regimes and 
temperatures on CMRO2:CBF in the normal brain.   
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Chapter 2 
Feasibility of Selective Brain Cooling Using a 
Nasopharyngeal Method in Piglets 
This chapter is adapted from the work entitled “Feasibility of Selective Brain Cooling 
Using a Nasopharyngeal Method in Piglets” by M Fazel Bakhsheshi, EE Stewart, JH Tai, 
L Keenliside and TY Lee, submitted to the Journal of Critical Care Medicine. The focus 
of this paper is to investigate the feasibility of cooling selectively the brain of normal 
new-born piglets with developed temperature regulation by spraying normal or 
humidified cooled air into the nasal cavities.   
2. Introduction 
 Clinical investigators have reported that mild and moderate hypothermia can be 
neuroprotective to reduce brain injury and decrease death and disability for a variety of 
acute brain injuries following severe head trauma, cardiac arrest, stroke and neonatal 
asphyxia.
1-3
 The neuroprotective benefits of hypothermia have been linked to the time to 
initiate cooling after injury, depth of cooling and re-warming rate.
4, 5
 Clinical studies 
indicate that the temperature range associated with better outcomes appears to be 32-
35°C
6, 7
 and has to be achieved as quickly as possible.
8, 9
 However, cooling the whole 
body below 34°C can cause complications including , shivering, sclerema, skin erythema, 
renal failure, coagulopathy, pulmonary hypertension and increased mortality.
10, 11
 
Moreover, it may decrease perfusion and oxygenation by impairing myocardial 
contractility, reducing cardiac output and making myocardial muscle more prone to 
arrhymia
12, 13
; as well as causing pulmonary vasconstriction and increasing blood 
viscosity.
14, 15
 Such complications along with other ones offset the benefits accrued from 
the neuroprotective effects of hypothermia. Therefore, in order to avoid the complications 
associated with systemic hypothermia, it is very important to develop a selective brain 
cooling (SBC) approach that can be initiated as early as possible to reduce the 
temperature of the brain tissue uniformly. 
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 Based on anatomical features, blowing cold air into the nasopharynx may offer the 
capability to cool the brain selectively by cooling blood in both internal carotid arteries 
via counter-current heat exchange mechanism with the neighboring cavernous sinuses 
which collect cold venous blood from the mucosal linings of the nasal cavities. 
Furthermore, cerebrospinal fluid (CSF) chilled at the basal cistern cools the whole brain 
through the CSF circulation (Figure 2.1). In the present study, we evaluate the feasibility 
and efficiency of nasopharyngeal SBC by blowing room temperature or cold air (medical 
air) into the nostrils at two different flow rates on normal new-born piglets with 
developed thermal regulation. 
 
 
Figure 2.1. (a) Cerebral blood and brain are chilled by heat exchange between internal carotid 
arteries and cavernous sinuses and; (b) cerebrospinal fluid also cools the whole brain through the 
circulation.  
Figure (a) adapted from Bhatti et al.
16 
50 
 
2.1 Materials and Methods 
2.1.1 Animals preparation and experimental procedure 
 Experiments were conducted on thirty-two piglets. All animal experiments were 
approved by the Animal Use Subcommittee of the Canadian Council on Animal Care at 
the University of Western Ontario. Newborn Duroc cross piglets were obtained from a 
local supplier on the morning of the experiment. Piglets were anesthetized with 3-4% 
isoflurane during preparatory surgery. A tracheotomy was performed and the piglet was 
ventilated with a volume-controlled mechanical ventilator to deliver oxygen/medical air 
mixture (2:1). A femoral artery was catheterized to monitor heart rate (HR) and mean 
arterial blood pressure (MAP) and to intermittently collect arterial blood samples for gas 
(paCO2, paO2), pH and glucose analyses. Arterial CO2 tension (paCO2) was monitored 
throughout the experiment, either directly by blood gas measurements or by the end-tidal 
CO2 tension, and maintained at normocapnia between 37-42 mmHg by adjusting the 
breathing rate and volume. Arterial oxygen tension (paO2) was maintained at a level 
between 90-130 mmHg by adjusting the ratio of oxygen to medical air. Blood glucose 
was monitored intermittently and if it fell below 4.5 mmol/L, a 1-2 ml infusion of 25% 
glucose solution was administered intravenously. Rectal temperature was recorded from a 
rectal probe inserted to 3-4 cm from the anal margin. Deep brain temperature was also 
measured continuously with a thermocouple probe. A burr hole 1.5 cm posterior to the 
bregma along the mid-line was made in the skull with a Dremel tool. The needle 
thermocouple probe was inserted through the burr hole into the brain to a depth of 2 cm 
from the brain surface to measure brain temperature. After surgery, each piglet together 
with a recirculating heated water blanket were wrapped with linen blankets, maintained 
on 1-2% isoflurane, and randomized to receive one of four different nasopharyngeal 
cooling treatments which involved blowing either room or cold air at either one of two 
flow rates into both nostrils of piglets: 
I. Room temperature at a flow rate of 3-4 L.min-1(n=6); 
II. -1 ± 2°C at a flow rate of 3-4 L.min-1(n=6); 
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III. Room temperature at a flow rate of 14-15 L.min-1(n=6); 
IV. -8 ± 2°C at a flow rate of 14-15 L.min-1 (n=9)  
To control for the normal thermal regulatory response of piglets without nasopharyngeal 
cooling, a control group of piglets (n=5) had their brain temperature monitored without 
nasopharyngeal cooling.   
2.1.2 Method of nasopharyngeal brain cooling 
 Nasopharyngeal brain cooling was achieved by directing room temperature or 
cooled air via a catheter in each nostril into the nasal cavities. Each catheter was 
lubricated with 2% lidocaine gel for anaesthesia and inserted 4-5 cm into each nostril. Air 
was delivered into the nasal catheters from a pressurized tank through a flow regulator, a 
pump and a cooling unit (Polyscience refrigerated/heated circulating bath). The circuit 
was customized by replacing the pump tube with a double-walled tube with circulating 
cooling liquid (Ethylene glycol) in the outer tube and directing air through the inner tube 
(Figure 2.2). Before starting the cooling process, the cooling unit was set to -25°C with a 
temperature stability of ±0.05°C over 30-45 min; the same settings were kept during the 
entire experiment. Induction of hypothermia was initiated by directing air at the required 
temperature, either -1 ± 2°C or -8 ± 2°C measured at the tip of the nasal catheter and flow 
rate, either 3-4 or 14-15 L.min
-1
, into the nasal catheters. Once the brain temperature 
stabilized, the flow rate was decreased to 0.5-1.5 L.min
-1
 to maintain the lower 
temperature reached. Before the onset of hypothermia induction, the core temperature of 
all animals was stabilized at 38 ± 0.5°C for an hour by turning the recirculating heated 
water blanket on and off.  
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2.1.3 H&E histopathological examination 
 The piglets were sacrificed at the end of the experiment by intravenous injection 
of potassium chloride (1-2 ml/kg) while on 5% inhaled isoflurane. For each piglet, the 
brain and the snout were excised. Coronal sections of the brain (cut into the 4-5 mm-thick 
sections) and the snout (at the region of the premolar tooth) were obtained. The tissue 
sections were fixed in 10% neutral buffered formalin for 24~48 hr, and then transferred 
into a phosphate buffer saline (PBS) solution for preservation. These tissue fragments 
were then paraffin-embedded, cut into 5 µm-thick sections and stained with Hematoxylin 
and Eosin (H&E) for histopathological examination. 
 
Figure 2.2. Schematic representation of the cooling circuit used for nasal cooling. The 7 Litre 
container was filled with a cryogenic cooling liquid (Ethylene glycol). 
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2.1.4 Statistical analysis 
 SPSS 17.0.0 (SPSS, Inc, Chicago, IL) was used for all statistical analyses. 
Normality of the distribution of the measurements was verified using Kolmogorov–
Smirnov (KS) test. Analysis of variance (ANOVA) was used to check the difference 
between the groups. Comparisons between time-based measurements within the groups 
were performed with analysis of variance repeated measurements. Statistical significance 
was based on p-value < 0.05. All data are presented as mean ± standard deviation (SD) 
unless otherwise noted. 
2.2 Results 
 Experiments were conducted on thirty-two piglets (17 females and 15 males), 
divided into four cooling groups and one control group as described in Section 2.1.1, with 
an average age of 47 ± 14 hours and an average weight of 2.7 ± 1.5kg. Table 2.1 presents 
the summary of the physiologic parameters of the piglets (MAP, HR, paO2 and paCO2) in 
Group I to IV and controls during cooling. All monitored physiological parameters 
showed decreasing trends during cooling but only HR and MAP decreased significantly 
(p<0.05) at the higher flow rate of 14-15 L.min
-1
 and lower temperature of -8 ± 2°C.   
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Table 2.1. Physiological parameters measured at different times during SBC with different 
methods.  
  Baseline Cooling 
  1-60min 30 min 1 hr 
MAP 
(mmHg) 
Control 36 ± 7 34 ± 6 36 ± 7 
Group I: 3-4 L.min
-1
 at RT 40 ± 2 37± 1 35 ± 3 
Group II: 3-4 L.min
-1
 at -1±2°C  33 ± 3 30 ± 2 28 ± 5 
Group III: 14-15 L.min
-1
 at RT  41 ± 4 39 ± 3* 36 ± 5* 
Group IV: 14-15 L.min
-1
 at -8±2°C  35 ± 7 32 ± 6* 30 ± 6* 
HR (bpm) 
Control 162 ± 16 163 ± 15 162 ± 16 
Group I: 3-4 L.min
-1
 at RT 139 ± 10 132 ± 9 128 ± 21 
Group II: 3-4 L.min
-1
 at -1±2°C  158 ± 16 154 ± 22 143 ± 25 
Group III: 14-15 L.min
-1
 at RT  149 ± 15 135 ± 22* 125± 25* 
Group IV: 14-15 L.min
-1
 at -8±2°C  164 ± 15 145 ± 16* 133± 19* 
paCO2 
(mmHg) 
Control 39 ± 3 40 ± 3 39 ± 3 
Group I: 3-4 L.min
-1
 at RT 40 ± 2 38 ± 2 39 ± 1 
Group II: 3-4 L.min
-1
 at -1±2°C  40 ± 2 39 ± 2 38 ± 4 
Group III: 14-15 L.min
-1
 at RT  39 ± 2 39 ± 2 37 ± 1 
Group IV: 14-15 L.min
-1
 at -8±2°C  40 ± 3 39 ± 2 38 ± 2 
paO2 
(mmHg) 
Control 131 ± 44 133 ± 32 125 ± 30 
Group I: 3-4 L.min
-1
 at RT 129 ± 19 99 ± 20 93 ± 14 
Group II: 3-4 L.min
-1
 at -1±2°C  117 ± 15 110 ± 7 92 ± 13 
Group III: 14-15 L.min
-1
 at RT  103 ± 24 95 ± 19 94± 30 
Group IV: 14-15 L.min
-1
 at -8±2°C  129 ± 3 111 ± 2 104 ± 2 
RT: Room Temperature; * a statistically significant (P<0.05) difference compared to the baseline. 
 Figure 2.3 displays the average cooling rates achieved with different 
nasopharyngeal cooling methods and the brain temperature as a function of time for each 
method. At the low flow rate of 3-4 L.min
-1
 mean brain cooling rate was significantly 
greater (p<0.05) with -1 ± 2
o
C than room temperature air. Using either room temperature 
or chilled air (-1 ± 2
o
C or -8 ± 2
o
C), there was statistically significant (P<0.05) greater 
brain cooling rate with high (14-15 L.min
-1
) than low (3-4 L.min
-1
) flow rate. In the 
control group, both rectal and brain temperature did not drop more than 0.5°C (brain: 0.35 
± 0.3°C; rectal: 0.35 ± 0.3°C).  
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(a) 
 
(b) 
Figure 2.3. (a) Mean brain cooling rate with different nasopharyngeal cooling methods; (b) Changes 
in brain temperature over time for each method in Figure 2.3(a). * signifies a statistically significant 
(P<0.05) difference between high flow rate versus low flow rate at both cold and room temperature; # 
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signifies a statistically significant (P<0.05) difference between cold temp versus room temp at low 
flow rate (3-4 L.min
-1
). 
 Following 60 minutes of baseline to demonstrate relatively constant brain (38.8 ± 
0.2°C) and rectal (38.4 ± 0.2°C) temperature over this period, brain temperature started 
falling immediately after the initiation of nasopharyngeal cooling with room temperature 
air at a flow rate of 3-4 L.min
-1
. One hour post cooling, the brain and rectal temperatures 
were 37.1 ± 0.9°C and 37.2 ± 0.5°C which resulted in mean brain cooling rates of 1.7 ± 
0.9°C/h and 1.4 ± 0.9°C/h, respectively as displayed in Figure 2.4(a).   
 
 (a)  
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(b) 
Figure 2.4. Brain and rectal temperature over time for nasopharyngeal cooling method with (a) 
room temperature and (b) -1 ± 2°C air at a flow rate of 3-4 L.min
-1
.  
 With the air flow rate at 3-4 L.min
-1
, the brain and rectal cooling rates were 
increased by decreasing the air temperature to -1 ± 2°C by circulating cryogenic cooling 
liquids in the outer tube of the double-walled pump tube. Figure 2.4(b) shows both brain 
and rectal temperature decreased from 38.4 ± 0.7°C and 38.2 ± 0.7°C to 34.8 ± 1.7°C and 
35.3 ± 1.7°C which corresponded to cooling rates of 2.6 ± 1.1°C/h and 1.8 ± 0.6°C/h, 
respectively. Figure 2.4 shows that it was possible to maintain brain at the temperature 
arrived at after an hour of cooling with a variation of 0.35 ± 0.45°C by decreasing the air 
flow rate to 0.5-1.5 L.min
-1
. No significant differences were found between brain and 
rectal cooling rates for either air temperature at the flow rate of 3-4 L.min
-1
. During the 
baseline monitoring period, brain and rectal temperatures variations were the same (brain: 
0.4 ± 0.4°C; rectal: 0.4 ± 0.5°C). 
 By increasing flow rate to 14-15 L∙min
-1
 at room temperature, Figure 2.5(a) 
demonstrates that brain and rectal temperature could be reduced more rapidly at mean 
rates of 4.3 ± 1.2°C/h and 3.7 ± 1.2°C/hr respectively. Mean brain temperature decreased 
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to 33.7 ± 1.7°C within approximately 60 min of cooling from baseline (38.2 ± 1.1°C). 
Figure 4.5(b) shows even greater cooling rate by using -8 ± 2°C air at the same flow rate. 
Both brain and rectal temperature decreased from 38.4 ± 0.8°C and 38.1 ± 0.8°C to 32.8 ± 
1.1°C and 35.1 ± 0.7°C which corresponded to a 5.5 ± 1.1°C/h and 3.2 ± 0.7°C/h, 
respectively. At this higher air-flow rate of 14-15 L∙min-1, there were significant 
differences between brain and rectal temperature during cooling for either room 
temperature or -8 ± 2°C air. After cooling with room temperature or -8 ± 2°C air at a flow 
rate of 14-15 L∙min-1 (but not with 3-4 L∙min-1), the rectal temperature continued to 
decrease during the following 30 minutes when the air flow rate was decreased to 0.5-1.5 
L.min
-1
 to maintain the brain temperature (Fig. 2.5 vs Fig. 2.4). 
 
 
 (a) 
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      (b) 
Figure 2.5. Brain and rectal temperature over time for nasopharyngeal cooling method with (a) 
room temperature and (b) -8 ± 2
o
C air at a flow rate of 14-15 L.min
-1
. * signifies a statistically 
significant (P<0.05) difference between brain and rectal temperature. 
 Brain-body temperature gradient, calculated as the difference between brain and 
rectal temperature, for room temperature or -8 ± 2°C air at the flow rate of 14-15 L∙min-1 
over the baseline and the cooling period is shown in Figure 2.6. The temperature gradient 
reached -1.75 ± 0.7°C after 20 minutes of cooling and remained significant (p<0.05) 
during the rest of cooling period (Figure 2.6(b)).  
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 (a) 
 
(b) 
Figure 2.6. Changes in the brain-rectal temperature over time for intra-nasal cooling method with 
setting the air flow rate to 14-15 L.min
-1
 at (a) room temperature and (b) cold temperature. * a 
statistically significant (P<0.05) difference compared to the baseline. 
Figure 2.7 (a) to (c) show H&E histopathological examination results of the frontal lobe 
of the brain and nasal conchae (turbinates) from the nasal cavity of a piglet. There were 
no pathological findings of bleeding, erythema and blister in the turbinates and of 
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necrosis in the frontal lobe of brains in both gross and H&E histopathological 
examinations. 
 
                 
Figure 2.7. Representative H&E histology shows (a) normal brain cells in grey and white matter of 
the frontal lobe and (b) & (c) intact pseudostratified cilia and conchae (turbinates) cells in the nasal 
cavity after the nasal cooling process. 
2.3 Discussion 
 Hypothermia in the porcine brain can be achieved via three mechanisms: surface 
cooling of superficial venous blood which in turn cools the arterial blood supply to the 
brain; cooling of head skin, from which cooled venous blood in the scalp flows via 
diploic and emissary veins to the brain (venous sinuses); and heat loss from the upper 
airway.
17-20
 The latter two are thought to be mechanisms of SBC, i.e. lowering brain 
temperature locally or as a whole below core trunk temperature.
21
 In particular, veins in 
500 µm 
 
200 µm 
 
(b) (c) 
(a) 
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the nasal mucosa of the upper airway drain into the cavernous sinus, a plexus (network) 
of thin-walled veins, which closely intertwines with the carotid rete mirabile. Carotid rete 
represents a vast vascular network at the base of the brain arising from branches of the 
carotids before entering the circle of Willis. This intricate network comes into close 
contact with the cavernous sinus which receives cool blood from the mucosa surfaces of 
the nose. Furthermore, in species with carotid rete, it has been shown that blood flow in 
the anglularis oculi vein (AOV), which is responsible for up 80% of SBC, increases with 
low nasal temperature.
22
 In non-human species that do not have carotid rete, the large 
surface of cavernous sinus, which is in close contact with the base of the brain, was 
shown to provide the necessary heat exchanger and to make regional cooling of the brain 
possible.
23, 24
  
 When the nasal cavity is cooled down as in our study, SBC is achieved via heat 
exchange at the cavernous sinus between cold venous blood from nasal mucosa and warm 
arterial blood in the carotid rete mirabile on route to the brain.
25
 Based on this heat 
exchange method, we showed that SBC can be achieved by blowing -8 ± 2°C air at a flow 
rate of 14-15 L∙min-1 into the nasal cavity: the brain temperature dropped from 38.1 ± 
0.8°C to 32.8 ± 1.1°C in 60 minutes or a cooling rate of 5.5 ± 1.1°C/h while the body 
temperature as measured by the rectal temperature probe was > 35
o
C during cooling.  
Similarly, Covaciu et al., demonstrated the method of selectively cooling the brain 
(≈3°C/h) with cold saline (8-10°C) circulating in balloon catheters placed into the nasal 
cavities of large pigs.
26
 Likewise, Wolfson et al., employed transnasal evaporative 
cooling system by spraying of perfluorocarbon liquid (perfluorohexane, PFH; F2 
Chemicals) at room temperature which was driven by compressed oxygen into the nasal 
cavities to achieve average intra-nasal brain cooling rate of ≈4°C/h in sheeps.27 The 
influence of nasopharynheal cooling on brain temperature under different range of 
circulatory states such as untreated cardiac arrest ("no-flow") or during normal circulation 
("normal-flow") and cardiopulmonary arrest (CPR) situation ("low-flow") was also 
shown in a porcine model in a study by Boller et al.
28
 Nasopharyngeal cooling device, 
RhinoChill (BeneChill, Inc, SanDiego, Ca, USA), shows that the brain is preferentially 
cooled compared with the other compartments of the body with a average cerebral 
temperature decrease of -4.7°C for normal flow, -4.3°C for no flow and -3.4°C for low 
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flow after 60 minutes.
28
 However, the brain-body temperature gradient was greatest in 
"no-flow" group which was nearly 4°C, while the smallest gradient was 2°C during 
normal blood flow.
28
 Intranasal cooling was beneficial even after prolonged cardiac arrest 
in a porcine model, where it significantly improved the return of spontaneous 
resuscitation (ROSC) rate and reduced CPR duration.
29, 30
 The administration of cold 
nasal airflow and intranasal cooling were both tested in human studies.
19, 31-34
 These 
methods proved to be feasible, safe and improved the neurological outcome. However, 
evaluating the effect of selective cooling methods on the human brain is challenging 
because direct measurements of the brain temperature cannot be made without the need 
for surgery. Furthermore, invasive temperature measurements do not inform on the intra-
cerebral distribution of temperature changes induced by these methods. 
 In humans, it was argued that the face and the surface of nasal mucosa as source 
of cool venous blood are small in relation to the mass of the brain and the carotid rete, 
where heat exchange might occur, does not exist.
20
 Moreover, a substantial fraction of the 
blood supply to the brain is via the vertebral arteries, which have no direct contact with 
cool venous blood. Because humans do not have a carotid rete, some have suggested that 
there is no counter-current heat exchange in the cavernous sinus and, as a result, human 
SBC is not possible. Yet the rete is not prerequisite for SBC because several other 
mammals without carotid rete clearly demonstrate SBC.
24, 35
 Consequently, lack of a 
carotid rete does not preclude the existence of SBC in humans or other mammals. The 
internal carotid artery in humans is tightly surrounded by the venous plexus caroticus and 
thereafter immersed in the cavernous sinus, and the vertebral arteries surrounded by a 
plexus of veins where they course through the transverse foramina.
20
 The blood 
temperature of the cavernous sinus decreases in response to chilled venous blood and 
selectively cools the brain by means of heat exchange mechanism with the arterial blood. 
Other components of the SBC system in humans are also thought to be cooling of head 
skin via emissary and angular veins, CSF circulation and the upper respiratory tract.
18, 36, 
37
 Mariak et al. directly demonstrated that increases or decreases in upper airway 
ventilation gave proportional changes of intracranial temperatures supporting the 
existence of this mechanism of brain cooling in human.
33
 Moreover, It has been shown 
that the nasal mucosa blood flow increases 3-fold during hyperthermia conditions in 
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humans and the cold venous blood flows via the angularis oculi vein to the brain, as in 
other species.
38, 39
 A continuous and cold nasal airflow in patients was found to reduce 
brain temperatures between 0.15-0.8°C.
19, 33
 Similarly, Dohi et al., achieved a lower 
cooling rate of ≈2.5°C/h by blowing 24-26°C air at a flow rate of 8-12 L.min-1 directly 
into the nasal cavities of two patients with Foley catheters adjunct with surface cooling.
34
 
Recently, feasibility of preclinical transnasal evaporative cooling was successfully tested 
in patients after cardiac arrest.
31, 32
 Castrén et al. demonstrated that the RhinoChill 
intranasal cooling device was effective to reduce of tympanic temperature within the Pre-
ROSC Intranasal Cooling Effectiveness trial (PRINCE trial).
32
 This method was able to 
show a significant decrease of tympanic temperature in the treatment group on arrival at 
hospital (34.2°C versus 35.5°C). However, benefit towards survival and neurological 
outcome was observed in the subgroup of cooling patients in whom CPR was initiated 
within 10 minutes after collapse, although the design of the study was not conceived for 
outcome analysis. In summary, prehospital treatment of patients with a cardiac cause of 
the arrest may increase the rate of favorable outcome at hospital discharge.  
 The RhinoChill device vaporises perfluorchlorcarbon along with oxygen at flow 
rate of 60-80 L.min
-1
 with a catheter system into the nasal cavity leading to a fast 
induction of hypothermia first to the brain as main target organ and second to the body 
with a slight delay.
32
 However, Perfluorocarbons raise environmental and health issues. 
They are powerful greenhouse gases and deplete the ozone layer and are listed as toxic 
substances under the Canadian Environmental Protection Act (CEPA).
40
 Another safety 
concern is the risk of coolant aspiration which might cause lung damage over prolonged 
periods since neural protection therapy may involve mild hypothermia being maintained 
for a period of 72 hours.
41
 Therefore, new cooling methods should be effective in terms of 
safety, fast cooling rates and easy to apply in the pre-clinical setting. We explored a 
method of nasopharyngeal cooling by continuously blowing room temperature or 
humidified cold air into the nostrils at different conditions on normal new-born piglets 
with developed thermal regulation. Piglets were studied because they are commonly used 
animal model of newborn human neurology.
42
 Thermoregulatory response in newborn 
piglets were progressively achieved after 48 hours of birth.
43
 In our study, brain 
temperature dropped with a mean cooling rate of 1.7 ± 0.9°C after the start of cooling 
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procedure, by setting the air-flow rate to 3-4 L.min
-1
. The rate of brain cooling can be 
improved by increasing the air-flow rate and/or decreasing the temperature of circulating 
cryogenic cooling liquids in outer tube of heat exchanger. Brain temperature reduced 
more rapidly at a rate of 5.6 ± 1.1°C/h with increasing air-flow to 14-15 L.min
-1
 at cold 
temperature. Rectal temperature continued to drop till it reached to the brain temperature 
during maintaining period. The decline in rectal temperature following the brain 
temperature may be due to the balance between heat production in the rest of the body 
and heat lost through cold air-flow in nasal cavities. Regardless of cooling conditions, HR 
and MAP decreased with cooling. The level of gaseous carbon dioxide, or PaCO2, in 
arterial blood depends on the solubility coefficient of this gas, which is dependent on 
temperature and decreases as temperature decreases.
44
 The CO2 gas crosses the blood-
brain barrier and transmits the induced modifications (e.g., alkalosis in hypothermia)
45
 to 
the extracellular environment, which regulates the state of arteriolar vascular tone. This 
explains why hypothermia-induced hypocapnia may cause arteriolar vasoconstriction and 
a decrease in intracranial pressure.
14
  
 Several factors could have influenced the possibility that the results in the 
experimental studies could be reproduced in humans. Firstly, in all of the experimental 
studies anaesthesia was maintained with Isoflurane. All general anaesthetics increase the 
threshold for sweating and decrease the thresholds for vasoconstriction and shivering.
46
 
Secondly, there are anatomical and physiological differences between new-born piglets 
and humans that are important in this context. The baseline temperature in newborn 
piglets and humans is different. Pigs differ considerably to humans in their ratio between 
the size of their nasal cavity and their brain. Importantly, the newborn piglets, in contrast 
to humans, have a carotid rete that may be a SBC system specific for the pig. Based on 
the relatively rapid cooling rate achieved in this study by setting the air-flow rate to14-15 
L.min
-1
, we suggest that nasal cooling with this technique still has great potential for 
inducing hypothermia on large animal or human by increasing air-flow rate up to 60-80 
L.min
-1
 at cold temperature. In conclusion, we have demonstrated that nasopharyngeal 
cooling by spraying humidified and cooled air into nasal cavities is an effective, feasible 
and simple method to selectively reduce and maintain brain temperature of newborn 
piglets. This method can be easily implemented in hospitals and even on ambulances to 
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cool down the brain to ameliorate brain damage from hypoxia-ischemia in newborns, 
cardiac arrest in resuscitated patients, stroke and traumatic injury. 
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Chapter 3 
Monitoring Brain Temperature by Time-Resolved 
Near-Infrared Spectroscopy: A Pilot Study 
This chapter is adapted from the work entitled “Monitoring Brain Temperature by Time-
Resolved Near-Infrared Spectroscopy” by M Fazel Bakhsheshi, M Diop, K St. Lawrance 
and TY Lee, submitted to the Journal of Bio-Medical Optics. The focus of this paper is to 
investigate the potential of time-resolved near-infrared spectroscopy (TR-NIRS) to 
measure absolute temperature in tissue-mimicking phantoms (in-vitro) and deep brain 
tissue temperature (in-vivo).   
3. Introduction 
 Clinical studies have shown that hypothermia improves neurological outcome and 
reduces mortality following cardiac arrest, traumatic brain injury, birth asphyxia and 
ischemic encephalopathy.
1-3
 Despite its well-documented efficacy, the widespread 
application of hypothermia in neuro-emergencies has been hampered by the difficulty of 
noninvasively monitoring brain temperature. As well, cooling the whole body below 33-
34°C can induce severe complications including, sclerema, skin erythema, renal failure, 
coagulopathy, pulmonary hypertension, and even death.
4
 SBC methods, such as using a 
cooling helmet or nasopharyngeal cooling, have been proposed to alleviate the 
complications associated with systemic hypothermia by directly cooling the brain while 
maintaining body temperature to as close to normal as possible.
5
 However, SBC requires 
a method that can measure local brain temperature rather than body temperature  as the 
latter may not reflect the actual brain temperature. 
 Several approaches have been developed to assess brain temperature. Local brain 
temperature can be measured invasively by inserting a thermometer directly into the brain 
parenchyma, which provides accurate measurements but carries a significant risk of 
complications. Infrared tympanic thermometer is noninvasive; however, it does not 
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provide continuous monitoring and is sensitive to positioning errors.
6, 7
 Magnetic 
resonance spectroscopy (MRS) can be used to measure brain temperature
8
, but its clinical 
utility is hampered by a long measurement time and by the need to transfer patients to 
imaging facilities. Brain temperature measurement techniques have also been developed 
using other modalities such as ultrasound
9
, microwave radiometry
10
 and the zero-heat-
flux technique.
11
 However, these techniques suffer from practical issues such as inducing 
temperature increase, and poor temporal and spatial resolution. 
 Optical methods are a promising alterative to the aforementioned techniques since 
they are safe and the instruments are compact and portable. As well, temperature-
dependent changes in water absorption spectra have been well characterized by near-
infrared spectroscopy (NIRS).
12
 The water absorption peaks around 740, 840 and 970 nm 
shift to shorter wavelengths and increase in intensity with increasing temperature
12-14
, due 
to decreases in the extent of intermolecular hydrogen bonding among water molecules 
with increasing temperature. In fact, NIRS thermometry approaches based on broadband 
continuous wavelengths (CW) and diffuse correlation spectroscopy (DOS) have been 
developed to predict deep tissue temperature in an adult forearm and breast, 
respectively.
12, 15
 Chung et al. used the water peak at 970 nm to predict temperature in 
tissue mimicking phantoms and breast tissue.
15
 Using this water peak to monitor brain 
temperature is challenging because of the strong water absorption at this wavelength 
which limits depth penetration. In this study, the temperature-dependency of the water 
absorption peaks at ~740 nm and ~840 nm was investigated as an alternative approach for 
monitoring brain temperature. Although the temperature changes at these features are not 
as great as at 970 nm, this is compensated by the high water concentration in the brain, 
80-90% in the newborn brain.
16
 TR-NIRS was used in order to separate the effects of 
tissue scattering from absorption and to provide better depth sensitivity.
17
 The method 
was validated in tissue-mimicking phantoms by correlating TR-NIRS temperature 
calculations to simultaneous thermometer measurements, and was subsequently used to 
monitor brain temperature in newborn piglets during cooling. Deep brain temperature was 
also measured continuously with a thermocouple probe. 
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3.1 Materials and Methods 
3.1.1 Instrumentation 
 The light sources of the TR-NIRS system consisted of thermoelectrically cooled 
picosecond pulsed diode lasers (LDH-P-C, PicoQuant, Germany) emitting at 760, 810 
and 830 nm and a computer controlled laser driver (SEPIA PDL 828, PicoQuant, 
Germany). These emission wavelengths were chosen to quantify tissue chromophores 
(oxy-hemoglobin, HbO2 and deoxy-hemoglobin, Hb)
18
 and characterize temperature-
dependent changes of the water absorption peaks. The lasers’ output power and pulse 
repetition rate were set to 1.4 mW and ~27 MHz, respectively. The individual pulses of  
the three lasers were temporally separated by sharing the 80 MHz clock of the laser 
drivers. Light emitted by each diode laser was attenuated by two adjustable neutral 
density filters (NDC-50-4M, Thorlabs, Newton, NJ) and coupled by a microscope 
objective lens (NA = 0.25, magnification = 10x) into one arm of a trifurcated fiber bundle 
(three fibers; NA = 0.22, core 400 m, Fiber Optics Technology, Pomfret, Connecticut). 
The distal common end of the bundle (emission probe) was placed on the surface of the 
phantom (or scalp of the piglets) and held in position by a probe holder. The average 
power delivered to a subject was attenuated to ~20 W per laser, which is below ANSI 
safety limits for skin exposure.
19
 
 Photons emerging from the phantom (piglet scalp) were collected by a 2-m fiber 
optic bundle (NA = 0.55, 3.6 mm diameter active area, and 4.7-mm outer diameter, Fiber 
Optics Technology). The other end of the detection probe was secured in front of an 
electromechanical shutter (SM05, Thorlabs). Light transmitted through the shutter was 
collected by a Peltier cooled microchannel plate photomultiplier tube (MCP-PMT) (PMC-
100, Becker and Hickl, Germany). Detection of a photon generated an electrical pulse 
(amplitude of 50-200 mV, width = 1.5 ns) that was transmitted to a time-correlated single 
photon counting (TCSPC) module (SPC-134, Becker and Hickl, Germany) to build the 
temporal point spread function (TPSF).  
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3.1.2 Optical Properties Measurement 
 To quantify tissue optical properties (i.e., the absorption coefficient μa and the 
reduced scattering coefficient μs′) from the measured TPSFs, the instrument response 
function (IRF) was measured to account for dispersion by the system.
20
 The IRF was 
acquired by placing a thin piece of white paper between the emission fiber and the 
detection fiber bundle. The paper was coated with black toner to reduce specular 
reflection.
21
 IRFs were measured at the start and end of each experiment at the same 
count rate as the TPSFs (~800 kHz). Measurement of the optical properties was obtained 
using an analytical model of light diffusion.
22
 The model solution was first convolved 
with the measured IRF, and then a nonlinear optimization routine (MATLAB function 
fminsearch) was used to fit the convolved model to each measured TPSF to determine 
optical properties (μa and μs′) and scaling factor which accounts for laser power, any 
potential drift in the intensity of light source, detection gain, and coupling efficiency.
20
 
The fitting range was set to 80% of the peak value on the leading edge and 20% on the 
falling edge.
23
 The TPSFs measured at baseline (i.e., before initiation of cooling) were 
averaged and fitted to extract the baseline optical properties as well as the scaling factor. 
Thereafter, changes in light absorption caused by cooling were characterized by using μa 
as the only fitting parameter; μs′ and the scaling factor were set to their baseline values to 
improve the stability of the fitting procedure and reduce errors causing by cross-talk 
between fitting parameters i.e., μa-μs′.
12, 20
 However, temperature effects on the reduced 
scattering coefficients, presented in Table 3.1 and 3.3, determined using only the scaling 
factor as the fix parameter. Tissue optical properties at each temperature were determined 
from averaging of 32 TPSFs collected at a sampling interval of 10 s (i.e., 320 s). The 
maximum count rate was set to 1% of the laser repetition rate (800 kHz), to minimize 
pile-up effect.
24
 However, Diop et al. showed that the error resulting from distortions in 
TPSF shape was relatively small by measuring the IRF at the two extremes count rate 
(400 and 800 kHz).
25
 Finally, the measured changes in μa were used to calculate changes 
in temperature, as discussed in detail in the section 3.2. 
75 
 
3.1.3 Tissue mimicking Phantom Experiments 
 Tissue-mimicking phantoms (N = 7), composed of solutions of 95% distilled 
water, 0.8% intralipid and 4.2% whole piglet blood, were used for comparison of TR-
NIRS temperature calculations and thermometer measurements. Each solution together 
with a (magnetic) stirrer were placed in a Pyrex beaker on a heating and stirring plate. 
The emission and detector probes of the TR-NIRS instrument were positioned on the 
surface of the solution at a source-detector distance of 2 cm. A thermometer (VWR 
digital thermometer with 0.1°C precision, VWR International Inc) was also placed in the 
solution for concomitant TR-NIRS and temperature measurements. The phantom 
(solution) was stirred before each measurement to ensure homogeneity of both optical 
properties and temperature. Each experiment was completed within 3 hours during which 
the sample temperature was raised from ~32 to 38°C. The phantom and its container were 
weighed prior to heating, and again at the end of the experiment; the average total weight 
loss during the whole experiment was approximately 0.5 ± 0.3%. 
3.1.4 Animal Preparation and Experimental Procedure 
 In-vivo experiments were conducted on eight piglets (6 females and 2 males) 
whose average age and weight were 1.6 ± 0.7 days and 1.9 ± 0.4 kg, respectively. Animal 
experiments were approved by the Animal Use Subcommittee of the Canadian Council on 
Animal Care at Western University and conducted according to its guidelines. Newborn 
Duroc cross piglets were obtained from a local supplier on the morning of the experiment. 
Piglets were anesthetized with 1-2% isoflurane (3-4% during preparatory surgery). A 
tracheotomy was performed and the piglet was ventilated with a volume-controlled 
mechanical ventilator to deliver oxygen and medical air mixture (2:1). A femoral artery 
was catheterized to monitor heart rate (HR) and mean arterial blood pressure (MAP), and 
to intermittently collect arterial blood samples for gas analysis and measure of blood 
glucose levels. Deep brain temperature was also measured continuously with a 
thermocouple probe; a burr hole was drilled in the skull with a Dremal tool and a needle 
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thermocouple probe was inserted laterally through the skull into the brain to a depth of 2 
cm vertical from the brain surface and 1.5 cm posterior to the bregma along the mid-line. 
After surgery, a heated water blanket was used to maintain rectal temperature between 
37.5-38.5°C. Normocapnia (37-40 mmHg) was maintained throughout the experiment by 
adjusting the breathing rate and volume, depending on the arterial CO2 tension (pCO2) 
obtained from the blood samples or from monitoring end-tidal CO2 tension. Arterial 
oxygen tension (paO2) was maintained at a level between 90-130 mmHg by adjusting the 
ratio of oxygen to medical air at ventilator setting. Blood glucose was also monitored and 
1-2 ml infusion of 25% glucose solution was administered intravenously if blood glucose 
concentration fell below 4.5 mmol/L. 
 The experiment started at a delay of 60 min after the completion of the surgical 
procedures to allow time for the physiological variables (HR, MAP, pCO2 and paO2) to 
stabilize. This delay was also sufficient to minimize any drift artifacts in the TR-NIRS 
measurements.
26
 Piglets were placed in the prone position and a custom-made probe 
holder was strapped to the head to hold the emission and detection probes 2 cm apart, 
parasagittally, approximately 1.5 cm dorsal to the eyes directly in front of thermometer 
probe. Temperature was altered by placing plastic ice bags on the surface of the piglet’s 
body until the brain temperature decreased to 31-32°C over ~ 3 to 4 hours. For each 
experiment, the baseline count rate measured with the TR instrument was adjusted to 800 
kHz to match the count rate used to measure the IRF and was fixed for the remaining of 
the study. Tissue absorption coefficients were determined from reflectance data acquired 
continuously for 320 s at intervals of 10 s each. The entire experiment was completed 
within 5 hours. After the last measurement, the animals were sacrificed with intravenous 
potassium chloride (1-2 ml/kg) infusion. Thereafter, the brain was harvested and placed in 
paraformaldehyde (PFA) for 24 to 48 hours, and then transferred into a phosphate buffer 
saline (PBS) solution for preservation. Excised brains were later paraffin-embedded and 
cut into 5 µm-thick serial sections to verify the position of temperature probe and assess 
any potential bleeding caused by inserting the probe. 
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3.2 Data Analysis 
 A number of approaches have been developed to characterize the temperature 
dependence of the water absorption spectrum, including Gaussian component, classical 
and inverse least-squares, hybrid method and principal components analysis (PCA).
12
 In 
this study, TR-NIRS data were analyzed with PCA method to predict tissue temperature. 
It has been shown that PCA can reduce random errors compared to the other methods and 
improve the fitting to the model.
12
 
3.2.1 Temperature Fitting Algorithm 
The workflow to predict the temperature was as follows: 
(i) Hollis et al. described the calibration of pure water absorption spectrum 
against temperature as a combination of components, known as principal 
components, that vary linearly with temperature.
12
 As a first step, a data set (X) 
containing many independent variables was decomposed into two sets of linear 
variables. In matrix notation, principal component regression (PCR) can be 
described as follows: 
X=S.P, (3-1) 
where the rows of data matrix X (n×m) are the (n) pure water absorption spectra 
over (m) wavelengths at different temperatures at 0.1°C steps between 25°C and 
45°C used in the calibration. The rows of P (h×m) are the principal components of 
X, S (n×h) contains the components scores and (h) is the number of principal 
component used in the model. A MATLAB program was written to determine the 
principal components of the mean-centered data using an eigenvector 
decomposition technique.
27
 It has been shown that the first PC accounted for 99% 
of the total variance of the calibration absorption spectra.
12
 The next stage of the 
PCR calibration was to establish a linear relationship between the components 
scores and temperature.
12
 The model is defined as follows: 
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   t=S.v, (3-2) 
where t is the vector of the known calibration temperatures, v is the calibration 
vector relating the scores to the temperature. Equations (3-1) and (3-2) provide the 
principal components (matrix P) and calibration vector (v) that are used to predict 
the temperature from any spectrum.
12
 
(ii) The extinction coefficients of the major chromophores (H2O, HbO2 and 
Hb) were used to recover their concentrations from the absorption coefficients 
measured at the three wavelengths by TR-NIRS. Since the pure water absorption 
spectra were mean-centered for the PCR calibration, the mean water absorption 
coefficients from the calibration must also include to the fitting. Although the 
mean calibration coefficients could also be subtracted (rather than fitted to) from 
the measured tissue absorption coefficients: 
                                                      , (3-3) 
where µa(λ) is the absorption coefficient measured at wavelength λ, ci is the 
concentration of the i
th
 chromophore, ɛi(λ) is the extinction coefficient at λ, 
         is the the mean pure water absorption coefficient from the calibration at 
λ, Si is the score of the i
th
 loading vector, and Pi(λ) is a loading vector of the pure 
water at λ. In the first step, a least-square optimization algorithm (MATLAB 
function fminsearchbnd
28
) was used to extract the score of one pure water loading 
vector, i.e. PC, and concentrations of oxy- and deoxy-hemoglobin at baseline 
temperature by assuming a known water concentration of 95% and 85% for 
phantom and tissue experiments, respectively.
16, 29
 The optimization function is 
bound constrained, where bounds were applied to the recovered values to limits of 
search for oxy- and deoxy-hemoglobin concentrations to be in the range of 30-60 
µM
30
 and 5-25 µM
31, 32
, respectively. Note, the extinction coefficients of pure 
water as a function of temperature, oxy- and deoxy-hemoglobin used in this study 
were taken from literature.
33, 34
 
(iii) Predicted temperature was calculated by multiplying the scores of water 
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loading vectors found in the previous step by the calibration vector:  
                    , (3-4) 
where v is the calibration vector relating the scores to the temperature obtained in 
step (i). 
(iv) If the initial predicted temperature was different from the known 
temperature obtained by the thermometer at the beginning of the experiment, the 
Equation (3-3) from step (ii) was altered to include a constant in order to find the 
corrected score related to the pure water loading vector corresponding to the initial 
temperature. 
                                                    
        , 
(3-5) 
(v) The magnitude of the constant was determined using an iterative algorithm 
based on the criterion: 
               , (3-6) 
where 
                                                (3-7) 
(vi) For subsequent temperature predictions, the chromophore fitting was 
repeated with the constant obtained from the correction for initial temperature, and 
then tissue temperature was computed as described in step (iii).  
3.3 Statistical Analysis 
 SPSS 17.0.0 (SPSS, Inc, Chicago, IL) was used for all statistical analyses. 
Normality of the distribution of the measurements was verified using Kolmogorov–
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Smirnov test. Physiological parameters between different temperatures were then 
analyzed using one-way ANOVA. Correlations between the predicted temperatures 
against the temperatures measured by thermometry were analyzed using parametric linear 
regression. Finally, the degree of similarity between temperature measurements acquired 
with the two techniques was evaluated using a Bland-Altman plot.
35
 Comparisons of 
optical properties (μa and μs′) at different temperatures were analyzed by a repeated-
measures two-way mixed ANOVA to determine statistical differences as a function of 
temperature for different wavelengths. Statistical significance was based on p-value < 
0.05. All data are presented as mean ± SD unless otherwise noted.   
3.4 Results 
 Table 3.1 displays the temperature effects on absorption and reduced scattering 
coefficients for the tissue-mimicking phantom. There was a statistically significant 
increase in absorption coefficient when temperature increases above 36°C at all three 
wavelengths. The absorption coefficients were significantly lower at 760 nm than at 810 
and 830 nm while the reduced scattering coefficients were significantly higher at 760 nm 
than at 830 nm. No significant differences were found for reduced scattering coefficients 
between temperatures. 
Table 3.1. Absorption and reduced scattering coefficients measured at three discrete wavelengths 
as function of temperature in in-vitro (tissue-mimicking phantoms). Values are mean  SD. 
Variable       λ (nm) (38°C) (36°C) (34°C) (32°C) 
μa (mm
-1
) 
830 0.0175 ± 0.007
*†
   0.0152 ± 0.006
†
  0.0147 ± 0.005
†
 0.0142 ± 0.005
†
 
810 0.0155 ± 0.005
*†
   0.0134 ± 0.005
†
  0.0131 ± 0.005
†
  0.0127 ± 0.004
†
 
760 0.0118 ± 0.003
*
   0.0103 ± 0.003  0.0101 ± 0.003 0.0099 ± 0.003 
μs′ (mm
-1
) 
830      1.97 ± 0.19
†
   1.97 ± 0.15
†
      1.99 ± 0.14
†
        1.99 ± 0.12
†
 
810  2.06 ± 0.26  2.06 ± 0.21     2.05 ± 0.21       2.08 ± 0.20 
760  2.17 ± 0.22  2.16 ± 0.17    2.21 ± 0.21       2.21 ± 0.19 
* a statistically significant (P<0.05) difference compared to the baseline (32°C). 
†
 a statistically 
significant (P<0.05) difference compared to wavelength of 760 nm. 
 Figure 3.1 shows the measured against predicted temperature of the tissue-
mimicking phantoms. The average slope, intercept and R
2
 value from the individual 
regression analyses were 1.01, -0.16°C, 0.82. From the Bland-Altman analysis in Figure 
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3.1(b), the mean difference between the predicted and measured temperatures was 0.1°C. 
The 95% confidence interval of the difference between the two were 2.3°C to -2.1°C.  
 
(a) 
 
(b) 
Figure 3.1: (a) Correlation plot comparing temperature in the tissue-mimicking phantom calculated 
using data acquired by TR-NIRS against temperature measured with a thermometer (labeled 
Predicted Temperature and Measured Temperature, respectively). Each symbol type represents 
data from one of seven experiments with the tissue-mimicking phantom. The solid line represents the 
average of all individual linear regression lines and the dotted line indicates the line of identity (slope 
=1). (b) Bland-Altman plot comparing Predicted and Measured temperature. The dotted line shows 
the mean difference and dash-dotted lines show the limits of agreement (mean±2 SD) between the 
two temperature measurements. 
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 Table 3.2 provides a summary of the measured physiological parameters in piglets 
at the different brain temperatures. There was a statistically significant decrease in HR 
and PaO2 when temperature dropped to 34°C and lower. Analysis of the brain tissue 
sections revealed no gross hemorrhages caused by insertion of the thermometer probe into 
the brain. 
Table 3.2. Physiological parameters measured at different brain temperatures. Values are mean  
SD. 
 (38°C) (36°C)  (34°C) (32°C) 
MAP (mmHg) 42 ± 5  41 ± 4  40 ± 4 38  ± 4 
HR (bpm) 139 ± 10  125 ± 14
 
   109 ± 11
*
     94 ± 13
*
 
pH    7.4 ± 0.01      7.4 ± 0.02       7.4 ± 0.01   7.5  ± 0.1 
paCO2 (mmHg) 39 ± 1  38 ± 2   40 ± 1 38  ± 1 
paO2 (mmHg) 122 ± 15  93 ± 7      90 ± 17
*
     75 ± 17
*
 
Hb (µmol/L) 24.9 ± 9.2    25.4 ± 10.8     25.2 ± 11.2    26.7 ± 11.1 
HbO2 (µmol/L)   63.4 ± 20.9    62.9 ± 20.6     63.3 ± 19.9    61.5 ± 20.2 
tHb (µmol/L)   88.4 ± 22.3    88.3 ± 23.1  88.7 ± 22    88.9 ± 21.8 
MAP=mean arterial blood pressure; HR=heart rate; tHb=total hemoglobin; Hb=Deoxy-hemoglobin; 
HbO2=Oxy-hemoglobin. * a statistically significant (P<0.05) difference compared to the baseline 
(38°C). 
 Table 3.3 provides the measured μa and μs′ in the piglet brain at three wavelengths 
and at different temperatures. The absorption coefficient was higher at 830 nm than at 
810 and 760 nm and, as expected, the reduced scattering coefficient decreased as 
wavelength increased.
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Table 3.3. Absorption and reduced scattering coefficients measured at three discrete wavelengths 
as function of temperature in in-vivo (newborn piglets brain). Values are mean  SD. 
Variable    λ (nm) (38°C) (36°C)  (34°C) (32°C) 
μa (mm
-1
) 
830 0.0240 ± 0.005
†
 0.0242 ± 0.005
†
 0.0225 ± 0.005
†
 0.0177 ± 0.001 
810 0.0214 ± 0.003 0.0219 ± 0.004 0.0204 ± 0.003 0.0168 ± 0.002 
760 0.0214 ± 0.002 0.0223 ± 0.003 0.0212 ± 0.004 0.0173 ± 0.002 
μs′ (mm
-1
) 
830    0.68 ± 0.08
†
 0.67 ± 0.07
†
 0.67 ± 008
†
   0.67 ± 0.05
†
 
810   0.74 ± 0.10 0.74 ± 0.08 0.73 ± 0.11 0.80 ± 0.05 
760   0.79 ± 0.13 0.78 ± 0.11 0.73 ± 0.13 0.81 ± 0.12 
†
 a statistically significant (P<0.05) difference compared to wavelength of 760 nm. 
 Figure 3.2(a) shows a correlation plot comparing predicted brain temperature 
calculated using data acquired from TR-NIRS against temperature measured with a 
thermometer. Results from regression analysis for each piglet, as well as the average of  
all experiments are shown in Figure 3.2(a). From the Bland-Altman analysis in Figure 
3.2(b), the mean difference between the predicted and measured temperatures was 0.5°C. 
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The 95% confidence interval of the difference between the two were 2.7°C to -3.6°C. The 
average slope, intercept and R
2
 value from the individual regression analyses were 1.1, -
1.6°C, 0.66, respectively.  
 
(a) 
 
(b) 
Figure 3.2: (a) Correlation plot comparing temperature in the piglet brain calculated using data 
acquired by TR-NIRS against temperature measured with a thermometer (labeled Predicted 
Temperature and Measured Temperature, respectively). Each symbol type represents data from one 
of eight piglets. The solid line represents the average of all individual linear regression lines and the 
dotted line indicates the line of identity (slope =1). (b) Bland-Altman plot comparing Predicted and 
Measured temperature. The dotted line shows the mean difference and dash-dotted lines show the 
limits of agreement (mean ± 2SD) between the two temperature measurements. 
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3.5 Discussion 
 We investigated the ability of TR-NIRS technique to measure temperature in 
tissue-mimicking phantoms and newborn piglet’s brains using the temperature-
dependence of water absorption features around ~740 nm and ~840 nm during heating 
and cooling, respectively. The TR-NIRS temperature measurements in this study were 
based on subtle changes in the NIR water absorption characteristics due to macro-
molecular binding with the following assumptions. First, the concentration of water in the 
brain is assumed 85% in order to calculate the score of one pure water loading vector, i.e., 
one PC as well as cerebral hemoglobin concentrations. Second, the initial tissue 
temperature is known from thermometer to find the corrected score related to the pure 
water loading vector corresponding to this temperature. Third, to determine optical 
properties from changes in light absorption caused by cooling, the scaling factor and μs′ 
were set to the values determined from the baseline measurements and only μa was 
included as fitting parameter. This approach has been shown to improved the stability of 
the fitting procedure by limiting the number of fitting parameters as well as reducing 
cross-talk between parameters.
12, 20
 For example, including scaling factor or μs′ as a fitting 
parameter along μa resulted in a weak correlation of R
2  
= 0.68 and R
2  
= 0.57 between the 
TR-NIRS method and thermometer measurements for phantom experiments, respectively 
(data not shown). Furthermore, in our calculation, we assumed that the molar extinction 
coefficient of oxy- and deoxy- hemoglobin are constant over the temperature range of 39-
31°C. However, temperature-dependent changes of the hemoglobin NIR absorption 
spectra have been investigated
37
; it has been shown that with increasing temperature in 
the range of 20-40°C the amplitude of Hb and HbO2 decreased by 0.15-0.18% °C
-1
 and by 
less than 0.05% °C
-1
 and shifted by 0.08 nm °C
-1
 and 0.15 nm °C
-1
, respectively.
37
 
 The proposed method for calculating temperature were tested against direct 
thermometer measurement in tissue-mimicking phantom. Results demonstrate that TR-
NIRS was sensitive to temperature changes via changes in tissue water absorption 
coefficient and could measure the temperature of the tissue-mimicking phantom. A strong 
correlation (R
2 
= 0.82) of the predicted temperature calculated using TR-NIRS data to the 
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measured temperature with a thermometer was observed, with a slope of 1.01 indicating 
the equivalency between the optical and thermometer measurements over the temperature 
range of 33-38°C. The average difference between the TR-NIRS predicted temperature 
and the measured temperature was 0.15 ± 1.1°C.  
 For the in-vivo temperature measurement we used piglets because they are 
commonly used animal model of human newborn neurology
38
 and signal contamination 
from the minimal extra-cerebral tissue is relatively negligible, which enables the 
measured TPSFs to be modeled as the solution of the diffusion equation for a 
homogeneous semi-infinite geometry.
25
 A correlation between the thermometer measured 
and TR-NIRS predicted temperature was obtained (R
2  
= 0.66) with a slope of 1.1 over the 
temperature range of 39-31°C. There are thermoregulatory responses to a decline in body 
temperature, such as the effects of cold-induced vasoconstriction, reduction of mean 
arterial pressure and cardiac output.
39
 Vasoconstriction decreases the vascular space 
during hypothermia
40
, which decrease the volume of blood in the region probed by the 
TR-NIR light, and hence a reduction in μa. Moreover, the red blood cells are known to be 
a source of light scattering in tissue and typically occupies less than 2% of brain 
volume
41
, therefore a greater values of μs′ observed in in tissue-mimicking phantom 
compared with the piglet brain may be explained by higher concentration, i.e. ~4%, of 
whole blood used in solution. 
 There are a number of potential sources of error that could contribute to the 
discrepancy between the TR-NIRS predicted and thermometer measured temperature. 
One source of error is employing the pure water absorption spectrum and parameters 
associated with the temperature response that were used for fitting tissue temperature i.e., 
calibration vector and PCs. The difference in absorption spectrum between tissue and 
pure water is due to bound water within tissue.
42
 However, in our calculation, the 
chromophore fitting was performed with the loading vectors obtained from the PCR of 
the pure water absorption spectrum rather than that of ‘tissue water’, which resulted in the 
predicted temperature either underestimating or overestimating the thermometer 
temperature. A correction was performed using a constant value according to equation (3-
3) to make the predicted temperature as close as possible to the true initial temperature, 
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which was known from the thermometer. We also note that temperature prediction was 
not improved by the inclusion of more than one water loading vector, i.e. more PCs (only 
one was used in this study). Another potential source of error could be due to error in the 
determination of dispersion caused by the TR system (i.e. IRF of the system)
25
. In general 
the accuracy of the temperature prediction by our NIRS technique can be improved by 
having a continuous tissue absorption spectrum which offers better chromophore 
identification and improved concentration measurement of major tissue chromophores, 
i.e., water , oxy-, deox- hemoglobin and fat, particularly for water peak at 970 nm due to 
its greater temperature sensitivity and lower scattering in tissue. This can be done by 
combination of TR and CW spectroscopy, whereas most of the wavelength coverage is 
provided by a white-light CW measurement, and the TR data are acquired at a few 
selected NIR wavelengths. Measuring several μs′ values can be used in a simple function 
of wavelength to obtain estimates of μs′ across the entire wavelength range.
43
 With μs′ 
calculated and the measured CW reflectance, coefficients of absorption will be derived 
from the diffusion equation at all wavelengths in the spectral window of interest.
44
 
Another possible way to improve the reproducibility of the predicted tissue temperature 
by the NIRS technique would be to perform multiple measurements (predictions) at each 
temperature and calculate the average of the predicted temperatures. The major challenge 
in adapting this technique to adult patients is the significant signal contamination from 
superficial tissues. This is not a concern in neonatal applications, where the scalp and 
skull is negligible and it is reasonable to assume that all the collected light has traveled 
through brain tissue. However, in the adult subjects, the scalp, skull, and cerebral spinal 
fluid surrounding the brain can contribute significantly to absorption. In this case, it 
becomes very difficult to measure absolute concentrations of cerebral chromophores. It 
has previously been demonstrated that the depth sensitivity of the NIR signal is 
proportional to the distance separating emitter and detector
45
. This multi-distance, or 
depth-resolved approach allows the separation of information into superficial and deep 
components on the basis that light penetration increases with source-detector distance. 
Consequently, by collecting information at multiple distances simultaneously, it is 
possible to separate out information in terms of tissue layers, using an optical 
reconstruction approach.
46
 
87 
 
 In conclusion, we have demonstrated a method of monitoring tissue temperature 
non-invasively using the temperature response of water absorption peaks in the NIR 
spectral region. The results from tissue-mimicking phantoms show a strong correlation 
(R
2 
= 0.82) between the TR-NIRS method and thermometer measurements and we 
showed the potential of TR-NIRS method to measure temperature in-vivo in an animal 
model of the newborn. Since NIRS is safe and measurements can be obtained at the 
bedside in only a few minutes, it is believed that this technique could assist in monitoring 
of brain temperature in the neonatal intensive care unit during hypothermia therapy. 
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Chapter 4 
Coupling of Cerebral Blood Flow and Oxygen 
Consumption during Hypothermia under 
Different Anesthetics in Newborn Piglets 
Measured by TR-NIRS 
This chapter is adapted from the work entitled “Coupling of Cerebral Blood Flow and 
Oxygen Consumption During Hypothermia Under Different Anesthetics in Newborn 
Piglets Measured with a Time-Resolved Near-Infrared Technique”, submitted to the 
Biomedical Optics Express by: M Fazel Bakhsheshi, M Diop, K St. Lawrance and TY 
Lee. The focus of this paper is two-fold: to investigate the sensitivity of the TR-NIR 
technique to measure CBF during cooling at different temperatures, for validation, CBF 
was independently measured by CT perfusion at each temperature; and, to investigate the 
cerebral metabolic activity during hypothermia under different anesthetics.   
4. Introduction 
 Mild hypothermia (HT), in which the brain temperature is lowerd to 32-33°C, has 
been shown to be an effective neuoprotective therapy to reduce brain injury following 
cardiac arrest, traumatic brain injury and birth asphyxia and ischemic encephalopathy.
1
 
One of the important mechanisms of HT-induced neuroprotection is the preservation of 
brain ATP levels resulting from a reduction in cerebral metabolism or metabolic rate of 
oxygen (i.e. CMRO2).
2
 The effects of HT on CBF are a consequence of the well-accepted 
phenomenon that CMRO2 is closely coupled to CBF and therefore, a reduction in the 
former is coupled to a reduction in the latter.
3, 4
 Preserving the coupling between CBF and 
CMRO2 is an important factor in the control of the cerebral circulation, connecting the 
change in metabolic demands with the supply of substrates by blood flow. As a 
consequence of this balance between flow and metabolism, the oxygen extraction fraction 
(OEF) indicates any regional variation in brain. For example under oxidative stress, e.g. 
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ischemia-hypoxia, the OEF is increased from its basal value of ~30% leading to cerebral 
venous desaturation.
5-7
  
 Clinically, HT is typically induced under anesthesia to minimize brain damage, so 
it is important to determine whether the combination of anesthesia and HT alters flow-
metabolism coupling or deviates OEF from its basal values. Current methods to monitor 
changes in energy metabolism using PET and blood flow using MRI or CT are hampered 
by practical issues such as need to transfer patients to imaging facilities and prolonged 
scanning times, both of which are not practical for unstable patients. Therefore, a non-
invasive method that can be available over prolonged periods of cooling and rewarming 
phases is required since neural protection therapy may involve HT being maintained for 
periods of 72 hours.
8, 9
 Optical methods are promising alternatives to these current 
techniques since they are safe, the instruments are compact, portable and can provide 
physiological measurements at the bedside of patients. We have previously developed a 
dynamic contrast-enhanced NIR technique for measuring absolute CBF and CMRO2 
based on the Fick's Principle using a light-absorbing dye, indocyanine green (ICG), as an 
intravascular contrast agent.
10, 11
 
12
 However, there has been no previous study 
investigating feasibility of using time-resolved (TR) NIR technique to measure CBF and 
CMRO2 during HT. The purpose of the current study is two-fold: 
(i). Validate the TR-NIR CBF measurement against that measured using a CT 
perfusion technique at different temperatures during HT
13
; 
(ii). Investigate the coupling of CMRO2 and CBF under HT and different anesthetic 
combinations that may be used in clinical practice.  
 In the present study, CBF and CMRO2 were measured with a TR-NIR technique in 
newborn piglets in which brain temperature was lowered from ~38° to 33°C under three 
anesthetic regimes: isoflurane, propofol/nitrous oxide (N2O) and propofol/35-50% xenon 
(Xe35-50%). The latter regime (propofol/Xe35-50%) was used in the combined therapy of HT 
and Xe for neuroprotection in neurointensive care units (NICU)
14
; increasing 
neuroprotection from ~35% with HT32°C only to ~70% when HT32°C was combined with 
50% inhaled Xe gas.
15
 Although recent study has shown that neonates with (Hypoxic-
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Ischemic Encephalopathy) HIE undergoing HT have low CBF and CMRO2 when 
compared with healthy age-matched neonates
16
, there is no study examine the effect of 
HT on OEF alternations or flow-metabolism coupling under different anesthetic regimes 
and temperatures. Understanding how the combination of HT under different anesthetic 
may alter flow-metabolism coupling or deviates OEF from its basal values in the healthy 
brain is critical before extending these neuroprotective strategies to the injured brain. 
4.1 Materials and Methods 
4.1.1 Instrumentation 
 The light sources of the TR-NIR system are thermoelectrically cooled picosecond 
pulsed diode lasers (LDH-P-C emitting at 760, 810 and 830 nm, PicoQuant, Germany) 
activated by a computer controlled laser driver (SEPIA PDL 828, PicoQuant, Germany). 
The 760 and 830nm emission wavelengths were chosen to quantify tissue chromophores 
(oxy-hemoglobin, HbO2 and deoxy-hemoglobin, Hb) which were used to determine the 
cerebral oxygen saturation, while 810 nm laser coincides with the peak absorption 
wavelength of ICG in plasma. The output power and pulse repetition rate of the lasers 
were set to 1.4 mW and ~27 MHz, respectively. The individual pulses of  the lasers were 
temporally separated by sharing the 80 MHz clock of the laser driver among the three 
lasers. Light emitted by each diode laser was attenuated by two adjustable neutral density 
filters (NDC-50-4M, Thorlabs, Newton, NJ) and coupled by a microscope objective lens 
(NA=0.25, magnification=10x) into one arm of a trifurcated fiber bundle (three fibers; 
NA=0.22, core 400 m, Fiber Optics Technology, Pomfret, Connecticut). The distal 
common end of the bundle (emission probe) was placed on the scalp of the animal and 
held in position by a probe holder. The average power delivered to a subject was 
attenuated to ~20 W per laser, which is below ANSI safety limits for skin exposure.17  
 Photons emerging from the scalp were collected by a 2-m fiber optic bundle 
(NA=0.55, 3.6 mm diameter active area, and 4.7-mm outer diameter, Fiberoptics 
Technology). The other end of the detection probe was secured in front of an 
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electromechanical shutter (SM05, Thorlabs). Light transmitted through the shutter was 
collected by a Peltier cooled microchannel plate photomultiplier tube (MCP-PMT) (PMC-
100, Becker and Hickl, Germany). Detection of single photons generated electrical pulses 
(amplitude of 50-200 mV, width=1.5 ns) that were transmitted to a time-correlated single 
photon counting (TCSPC) module (SPC-134, Becker and Hickl, Germany) to generate 
the temporal point spread function (TPSF). As described in detail elsewhere
11
, tissue 
optical properties (i.e., the absorption coefficient μa and the reduced scattering coefficient 
μs′) were obtained using analytical solution of light diffusion to model the collected 
TPSFs . 
4.1.2 Determination of Cerebral Blood Flow 
 CBF was measured using a bolus-tracking method that requires an intravenous 
bolus injection of ICG (1 ml, 0.2 mg/kg) into a peripheral vein, followed by continuous 
measurements of the time-varying concentrations of the dye in arterial blood and brain 
tissue. The arterial concentration, Ca(t), was measured non-invasively by a dye 
densitometer (model DDG-2001 A/K, Nihon Kohden, Tokyo, Japan) with the probe 
attached to a front foot. Brain tissue concentration, Cicg(t), was determined from 
reflectance data acquired by the TR-NIRS instrument continually for 76s at a sampling 
interval of 400 ms. The two concentration curves are related by the following equation: 
                         (4-1) 
where * represents the convolution operator and [CBF.R(t)] is the flow-scaled impulse 
residue function or R(t). The function CBF·R(t) can be extracted from the arterial and 
tissue ICG concentration curves using a deconvolution algorithm
13
. The initial height of 
the derived function is CBF, since by definition R(0)=1, and the area under the curve is 
the cerebral blood volume (CBV).
18
 For the TR-NIR data, quantification of the brain 
concentration of ICG was determined from the measured change in μa
11
: 
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                                    (4-2) 
where μa(0) represents the baseline value determined over a 10-second period prior to an 
injection of ICG, and ICG is the extinction coefficient of ICG at 810 nm. 
4.1.3 Determination of cerebral metabolic rate of Oxygen 
 Measurements of CMRO2 were calculated
10
 using Fick's principle as follows: 
                        (4-3) 
The difference between the arterial concentration of oxygen, [O2]a, and the cerebral 
venous concentration of oxygen, [O2]v, is commonly referred to as the arterial-venous 
difference of oxygen (AVDO2), or the difference between the O2 concentration of the 
arterial blood feeding the tissue of interest and O2 concentration of the venous blood 
draining the tissue of interest. Equation (4-3) can be further expanded as follows
19
: 
                                 (4-4) 
where     ] is total hemoglobin concentration which can be measured from arterial 
blood samples.               are arterial and venous O2 saturation, respectively. The 
constant 1.39 is the O2 carrying capacity of hemoglobin measured in milliliters per gram 
of Hb. Note that the dye densitometer also provides continuous measurements of     , 
while      was determined indirectly from TR-NIRS measurements of average tissue 
cerebral blood oxygen saturation,            . This technique relies on the assumption 
that there exists a stable arterial-venous blood ratio in the CBV, i.e. 
                            (4-5) 
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where   represents the fraction of arterial blood in CBV. The relative distribution of 
arterial and venous compartments is generally accepted to be approximately 25% and 
75% in the total CBV, therefore to measure          was set to 0.25.
20, 21
 To obtain tissue 
cerebral blood oxygen saturation, i.e.,            , cerebral hemoglobin (HbO2, Hb) 
concentrations were calculated with TR-NIRS which relies on the assumption that there is 
stable concentration of water in the brain , i.e., ~85%
22
. These hemoglobin measurements 
were determined by fitting the tissue absorption coefficients to the extinction coefficients 
of the major chromophores, i.e., (water, Hb, HbO2). Tissue absorption coefficients were 
determined from reflectance data acquired continuously for 160s (i.e. 32 TPSFs) at a 
sampling interval of 5s.             can then be calculated as follows: 
            
    
       
   (4-6) 
Using this relationship, a new expression for       can be derived that is independent 
of     : 
                       
                 
   
   (4-7) 
The fraction of oxygen extracted from arterial blood into the brain, OEF, was calculated 
with the method described by Brown et al
10
: 
    
     
         
    (4-8) 
The tight coupling of CBF and CMRO2 in the normal brain leads to a fixed level of OEF 
around ~33%.
23
 A decoupling of the two, signifies oxidative stress, as in ischemia, and 
would lead to an increase in OEF beyond the normal value of ~33%.
6
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4.1.4 Animal Preparation and Experimental Procedure and Groups 
 Experiments were conducted on fifteen newborn piglets. All animal experiments 
were approved by the Animal Use Subcommittee of the Canadian Council on Animal 
Care at our institution. Newborn Duroc cross piglets were obtained from a local supplier 
on the morning of the experiment. Anesthesia was induced with 1-2% isoflurane which 
was increased to 3-4% during preparatory surgery. A tracheotomy was performed and the 
piglet was ventilated with oxygen and medical air mixture. A femoral artery was 
catheterized to monitor HR and MAP and to intermittently collect arterial blood samples 
for gas (paCO2, paO2), pH and glucose concentration analysis. A cannula was inserted into 
an ear vein for infusion of Propofol (AstraZeneca Pharmaceuticals, Canada Inc) and ICG 
(Sigma-Aldrich, Saint Louis, Missouri). After surgery, piglets were maintained on 1-2% 
isoflurane at normothermia (NT37°C). Arterial CO2 tension (paCO2) was monitored 
throughout the experiment, either directly by blood gas measurements or by the end-tidal 
CO2 tension, and maintained at normocapnia between 37-40 mmHg by adjusting the 
breathing rate and ventilation volume. Arterial oxygen tension (paO2) was maintained at a 
level between 90-130 mmHg by adjusting the ratio of oxygen to medical air. Blood 
glucose was monitored intermittently and if it fell below 4.5 mmol/L, a 1-2 ml infusion of 
25% dextrose solution was administered intravenously. Deep brain temperature was also 
measured with a thermocouple probe. The needle thermocouple probe was inserted 
laterally into the brain to a depth of 2 cm vertical from the brain surface and 0.5 cm 
posterior to the bregma. Animals were placed in a prone position and a custom-made 
probe holder was strapped to the head to hold the TR-NIRS emission and detection 
probes 2 cm apart, parasagittally, approximately 1.5 cm dorsal to the eyes. The 
experiments started after a delay of 60 min to allow time for the animals to stabilize 
following surgery. This delay was also sufficient for the TR-NIR instrument to reach a 
quasi-equilibrium to minimize drift artifacts in TR-NIR measurements due to temperature 
changes.
24
 Piglets were randomized into three groups:  
(i). Group I (N=7) had baseline (normothermia) CT and TR-NIR CBF measurements 
in the following order: one CT CBF scan, two TR-NIR CBF measurements 
separated by 10min before and after CT measurements. Following the baseline 
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(normothermia) CBF measurements, TR-NIR followed by CT CBF 
measurements were collected at ~2°C decrement from the baseline temperature 
of 38° to 32°C under isoflurane anesthesia; and,  
(ii). Group II (N=4) had two TR-NIRS measurements of CBF and CMRO2 under 
inhalational isoflurane (1-2%) anesthesia first and then both measurements were 
repeated under intravenous infusion of Propofol (9-22.4 mg/kg/h) and ventilation 
with 70% nitrous oxide (N2O 70%) and 30% oxygen (O2 30%) while brain 
temperature was changed from normo- (38°C) to hypo-thermia (35° and 33°C); 
and, 
(iii). Group III (N=3) was the same as Group II except that nitrous oxide and oxygen 
mixture was replaced by xenon/oxygen/nitrogen mixture (Xe 35-50%, O2 30-40%, N2 
10-20% respectively) using the closed-circuit Xe/O2 delivery system.
25
 
For propofol (10mg/ml) infusion, the rate was adjusted according to their responses, and 
change in vital signs such as blood pressure, and pain responsiveness of the piglet. The 
mean infusion rates were 2.51 ± 1.15 and 2.95 ± 1.11 ml/hr during propofol/N2O (Group 
II) and propofol/Xe (Group III) anesthesia, respectively. For normothermia, a heated 
water blanket was used to maintain rectal and brain temperature between 38°-38.5°C. For 
induction of HT, brain temperature was altered by exposing the piglet’s body to room 
temperature. For each anesthetic regime, two measurements of CBF and CMRO2 were 
collected per brain temperature. Each experiment was completed within 5 hours. After the 
last measurement, the animals were sacrificed with intravenous potassium chloride (1-2 
ml/kg) infusion.  
4.1.5 Computed Tomography Measurement 
 For Group I piglets, they were placed in a light speed 64-slice CT scanner (GE 
Healthcare, Waukesha, WI, U.S.A), the mobile TR-NIR apparatus was brought to the CT 
scanner and all TR-NIR measurements were obtained while the piglets remained in a 
prone position on the scanner table. Each CT CBF measurement began with a scout CT 
100 
 
scan to choose the locations of the CT slices to coincide with the position of the NIR 
optodes. To measure CBF, each piglet received a 1.0-mL/kg injection of the iodinated 
contrast agent iohexol (300 mg I /mL; Omnipaque™, GE Healthcare, Waukesha, 
Wisconsin), at a rate of 1.0 mL/s into the umbilical vein. Sequential (dynamic) CT scans 
were acquired using 80 kVp, 190 mA with the scanner once every second, for a period of 
40s. Each scan provided eight contiguous 5 mm thick coronal slices with a 12 cm field of 
view set to encompass the entire head and front legs of the piglet in a prone position. CBF 
map were generated from the serial image sets using CT Perfusion3 software (General 
Electric Healthcare). This package is based on the same deconvolution routine used to 
calculate CBF with the NIRS data and has been validated in our laboratory against the 
gold standard microsphere CBF measurement.
13
 Regions of interest (ROIs) manually 
drawn using an in-house developed in the IDL Development Environment (ITT Visual 
Information Solutions, Boulder, Colorado) program on the CT perfusion images that 
corresponded to the brain volume interrogated by the TR-NIR probes and mean CBF 
within the regions were averaged before comparison with the TR-NIR CBF. The ROIs 
only included the top ~1.5 cm of brain to account for the depth sensitivity of NIRS. 
4.1.6 Statistical Analysis 
 SPSS 17.0.0 (SPSS, Inc, Chicago, IL) was used for all statistical analyses. 
Normality of the distribution of the measurements was verified using Kolmogorov-
Smirnov (KS) test. Comparisons between temperature-based measurements within groups 
were performed by a repeated-measures one-way ANOVA when the variables were 
normally distributed (Group I) or, if the normality test failed, by the Friedman test 
(Groups II-III). Wilcoxon test was used to determine statistical differences when the 
anesthetic was switched from isoflurane to propofol/N2O (Group II) and propofol/Xe 
(Group III). Correlations between CT and NIRS CBF in Group I were analyzed using 
parametric linear regression. Statistical significance was based on p-value < 0.05. All data 
are presented as mean ± SD unless otherwise noted. 
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4.2 Results 
 Experiments were conducted on fifteen newborn piglets (9 females and 6 males), 
with an average age of 35 ± 12 hours old and an average weight of 1.7 ± 0.2kg. Due to 
difficulties to maintain normocapnia condition throughout the experiment, data from two 
piglets in Group I was excluded from analysis. Table 4.1 presents a summary of the 
averaged physiologic parameters of the piglets (MAP, HR, paCO2, paO2, pH, SaO2 and 
OEF) in the three groups, according to anesthetics used and brain temperature. In group I, 
there was a statistically significant decrease in HR and PaO2 (p<0.05) compared to 
baseline (normothermia) when temperature reached below 35°C. The heart rate dropped 
slowly with the induction of HT from 139 ± 10 to 94 ± 13 over the whole temperature 
range (38-32°C). In group II, when the anesthetic was switched from isoflurane to 
Propofol/N2O, there was a statistically significant increase in HR and MAP (p<0.05) 
compared to baseline (isoflurane); but HR started decreasing immediately after the 
initiation of cooling and return to baseline (isoflurane) level when temperature fell to 
35°C and a statistically significant decrease in paO2 when temperature fell below 35°C 
with the Propofol/N2O combination of anesthetics (p<0.05). No significant paCO2, SaO2, 
OEF or pH differences were found among different anesthetics and among different 
temperatures.  
 
 
 
 
 
 
 
102 
 
Table 4.1. Physiological parameters measured at different groups. 
 
 Baseline Cooling 
Variable  (38°C) (38°C) (35°C) (32°C) 
 
                     Baseline / Cooling   
 
 
MAP  
(mmHg) 
Group I    (isoflurane / isoflurane) 42 ± 5 42 ± 5 40 ± 4 38 ± 4 
Group II  (isoflurane / propofol/N2O)    42 ± 4  56 ± 6
*
   52 ± 2
*
    50 ± 11
*
 
Group III (isoflurane / propofol/Xe) 42 ± 5   45 ± 10 36 33 
HR 
(bpm) 
Group I    (isoflurane / isoflurane) 139 ± 10 139 ± 10
 
 117 ± 11
*
    94 ± 13
*
 
Group II  (isoflurane / propofol/N2O) 148 ± 5  226 ± 41
* 
195 ± 8
*
 138 ± 28 
Group III (isoflurane / propofol/Xe) 148 ± 7 168 ± 26 100 84 
paCO2 
(mmHg) 
Group I    (isoflurane / isoflurane) 39 ± 1 39 ± 1 41 ± 1 38 ± 1 
Group II  (isoflurane / propofol/N2O) 40 ± 2 41 ± 2 41 ± 1 40 ± 2 
Group III (isoflurane / propofol/Xe) 39 ± 2 41± 4 40 43 
paO2 
(mmHg) 
Group I    (isoflurane / isoflurane) 122 ± 15 122 ± 15     95 ± 17
*
 75 ± 17
*
 
Group II  (isoflurane / propofol/N2O) 155 ± 40 210 ± 49 136 ± 4
*
 85 ± 16
*
 
Group III (isoflurane / propofol/Xe) 164 ± 49 140 ± 43 101 89 
pH 
Group I    (isoflurane / isoflurane) 7.4 ± 0.02 7.4 ± 0.02 7.4 ± 0.03 7.4 ±0.04 
Group II  (isoflurane / propofol/N2O) 7.4 ± 0.06 7.4 ± 0.06 7.3 ± 0.09 7.3 ± 0.13 
Group III (isoflurane / propofol/Xe) 7.4 ± 0.04 7.4 ± 0.03 7.46 7.42 
SaO2 (%) 
Group II  (isoflurane / propofol/N2O) 100 97 ± 2 98 ± 1 97 ± 1 
Group III (isoflurane / propofol/Xe) 100 99 ± 1 99 100 
[O2]a 
Group II  (isoflurane / propofol/N2O) 0.11 ± 0.01 0.11 ± 0.02 0.11 ± 0.02 0.11 ± 0.01 
Group III (isoflurane / propofol/Xe) 0.12 ± 0.01 0.11 ± 0.01 0.11 0.11 
MAP=mean arterial blood pressure; HR=heart rate; [O2]a=arterial concentration of oxygen, *significantly 
(p<0.05) different from baseline. 
 Figure 4.1(a) is a coronal CT image of a piglet showing the holder and the 
positions of the two TR-NIR probes (white arrows). Figure 4.1(b-e) show coronal CBF 
maps at different temperatures and ROIs enclosing a ellipse-shaped trajectory that light 
travel from the source to the detector in each case. 
 
Figure 4.1. (a) Coronal CT image showing the location of the TR-NIR probes and the ROIs enclosing 
a ellipse-shaped trajectory that light travel from the source to the detector.  (b-e) Corresponding CBF 
maps at 38° (normothermia), 36°, 34° and 32°C. The region of interest used to measure CBF from the 
CBF map in each case is also shown. 
 Figure 4.2 shows that decreasing the brain temperature in Group I piglets (N=7) 
resulted in a decrease in TR-NIR CBF from 54.3 ± 5.4 to 33.8 ± 0.9 ml.min
-1
.100g
-1
 and a 
decrease in CT CBF from 56.8 ± 2.5 to 41.9 ± 2.1 ml.min
-1
.100g
-1
 at 38° and 32°C, 
respectively. 
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Figure 4.2. TR-NIR and CT CBF measurements in piglets (N=7) plotted as a function of brain 
temperature (N=7). 
 A correlation plot comparing CT and TR-NIR CBF and the corresponding Bland-
Altman plot are shown in Figure 4.3 The average slope, intercept and R
2
 value from the 
individual regression analyses were 1.3, -19 ml.min
-1
.100g
-1
, and 0.84 respectively. From 
the Bland-Altman analysis, the mean difference between the two methods was 5.84 
ml.min
-1
.100g
-1
. The 95% confidence limits of the difference between the two methods 
were from -15.3 to 27 ml.min
-1
.100g
-1
. 
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          (a) 
 
          (b) 
Figure 4.3. (a) Correlation plot comparing CT and the TR-NIR CBF. The solid line represents the 
average of all individual linear regression (slope = 1.3 and intercept = -19 ml.min
-1
.100g
-1
). (b) 
Bland-Altman plot of CT and TR-NIR CBF. The dotted line shows the mean difference and dash-
dotted lines show the limits of agreement (mean ± 2 SD). 
 Figure 4.4(a) displays TR-NIR CBF and CMRO2 measurements in Group II 
piglets (N=4) under two different anesthetic regimes (i.e., isoflurane only and 
propofol/N2O mixture) at three different brain temperatures. Both CBF and CMRO2 
values decreased from 50.42 ± 8.7 to 31.07 ± 8.7 ml.min
-1
.100g
-1
 and 2.46 ± 0.6 to 1.5 ± 
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0.4 mlO2.min
-1
.100g
-1
 at normothermia (38°C) when the anesthetic was switched from 
isoflurane to propofol/N2O and both decreased from 31.07 ± 8.7 to 23.9 ± 5.9 ml.min
-
1
.100g
-1
 and 1.5 ± 0.4 to 1.1 ± 0.01 mlO2.min
-1
.100g
-1
 in HT when brain temperature 
decreased from 38° to 33°C under propofol/N2O anesthesia. The OEF values under the 
different anesthetics and brain temperatures employed in group II, was plotted in Figure 
4.4(b). It shows that both HT and different anesthetics (i.e. isoflurane and propofol/N2O) 
did not deviate OEF from its basal values which expressing tight coupling of CBF to 
CMRO2; any change in metabolic demand were met by a corresponding change in 
substrate delivery via CBF modulation. 
 
           (a) 
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           (b) 
Figure 4.4. (a) Cerebral blood flow (CBF) and oxygen metabolic rate (CMRO2); and (b) Oxygen 
extraction fraction (OEF) in Group II piglets (N=4) at each cerebral temperature under isoflurane 
or propofol/N2O anesthetic regimes. Values are shown as mean ± SD; * p<0.05 versus at 38°C with 
isoflurane. 
 Figure 4.5(a) displays TR-NIR CBF and CMRO2 measurements in Group III 
piglets (N=3) under isoflurane and then propofol/Xe anesthesia at three different 
temperatures (only one piglet was cooled down to 33°C). Both CBF and CMRO2 values 
decreased from 49.4 ± 14.2 to 34.9 ± 12.1 ml.min
-1
.100g
-1
 and 2.3 ± 0.7 to 1.4 ± 0.53 
mlO2.min
-1
.100g
-1
 at normothermia (38°C) when the anesthetic was switched from 
isoflurane to propofol/Xe and decreased under propofol/Xe anesthesia from 34.9 ± 12.08 
to 23.6 ml.min
-1
.100g
-1
 and from 1.44 ± 0.53 to 1.05  mlO2.min
-1
.100g
-1
 respectively 
when brain temperature decreased from ~38° to 33°C. Similarly, Figure 4.5(b) shows that 
OEF remains unchanged under isoflurane anesthesia and under propofol/Xe anesthesia at 
different temperatures. 
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          (a) 
 
           (b) 
Figure 4.5. (a) Cerebral blood flow (CBF) and oxygen metabolic rate (CMRO2), (b) Oxygen 
extraction fraction (OEF) in Group III piglets (N=3) at each cerebral temperature under isoflurane 
or propofol/Xe anesthetic regimes. Values are shown as mean ± SD; * p<0.05 versus at 38°C with 
isoflurane. 
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4.3 Discussion 
 In the present study TR-NIR CBF measurements were validated against CT CBF 
measurements in a neonatal animal model in which brain temperature was lowered from 
38° to 32°C under isoflurane anesthesia. Our results revealed a linear correlation between 
two CBF measurement techniques, but the TR-NIR technique underestimated CBF 
measured with CT. There are a number of factors that can explain this discrepancy. One 
source of error is incorrectly characterizing the amount of dispersion caused by the TR 
system (i.e., variations between the measured and true instrument response function 
(IRF)).
11
 Additionally, this study used CT perfusion to validate the CBF which required 
selecting ROIs underneath the NIRS probe that corresponded to the area interrogated by 
the NIR light. The error in the CBF measurements caused by variable ROI selection can 
also explain the differences between two techniques. Another explanation is that the 
method to recovered optical properties is based on the diffusion approximation with the 
assumption that the light is propagating in a homogeneous semi-infinite geometry which 
is less true for the newborn model since the head size is significantly smaller than the 
adult.
26
 It has been shown that the model approximation can lead to errors in the 
recovered optical properties by 20% at short source-detector distances (5-20mm).
26
 In 
addition, the relatively thin layer of superficial tissues on the newborn head compromised 
of skin, muscle, and skull, could have an effect on the NIR signal and the accuracy of 
CBF measured with TR-NIR technique.
26, 27
 Although it becomes dominant in the adult 
case because of the larger thickness of the scalp and skull.
23,28
 Previous studies have 
reported that CBF collected using NIRS approaches can be underestimated by more than 
a factor of 3, due primarily to the increase in optical path length through extracerebral 
tissue.
29
  
 Furthermore, we examined the relationship between CMRO2 and CBF under 
normothermia (38°C) or mild whole-body HT (35° or 32°C) with different anesthetics , 
isoflurane(1-2%)/(N2 66%, O2 33%), propofol/(N2O 70%, O2 30%) or propofol/(Xe 35-50%, O2 30-
40%, N2 10-25%) which are representative of what may be used in clinical practice.
14, 30
 Our 
results showed that mild HT decreases both CBF and CMRO2  compared to normthermia 
109 
 
with preserved flow-metabolism coupling and constant OEF under different anesthetics. 
Flow-metabolism coupling within brain is a complex physiologic process that is regulated 
by a combination of metabolic, glial, neural, and vascular factors.
31-33
 In the normal brain, 
CBF is regulated by autoregulation, cerebrovascular and metabolic reactivity induced by 
changes in arterial carbon dioxide tension to maintain a tight coupling between CBF and 
CMRO2. However, during cerebral ischemic insults, alterations of cerebral hemodynamic 
and metabolism are highly dynamic. As cerebral perfusion pressure (CPP) falls, CBF is 
maintained by vasodilatation of resistance arterioles, known as autoregulation.
34
 When 
the capacity for compensatory vasodilatation has been exceeded, autoregulation fails and 
CBF falls as a function of pressure. When oxygen supply is diminished due to decreasing 
CBF, OEF increases in an effort to compensate for the reduced CBF and maintain a stable 
CMRO2 to preserve neuronal function and cellular integrity.
33
 If the CPP continues to 
fall, CBF will progressively decline until the increase in OEF is no longer sufficient to 
supply the oxygen to meet metabolic demand which causes to reduce CMRO2. Energy 
failure will result and permanent tissue damage may develop. Therefore, deviation of 
OEF from its basal value may be a more specific marker to monitor for oxidative stress 
from whatever causes that can lead to cerebral dysfunction.  
 The vasodilating effects of isoflurane have limited its use as a sedative agent in 
the NICU because of the fear of a potential increase in intracranial pressure (ICP) caused 
by the increase in CBF.
35
 However, propofol is being used more frequently in the 
neurosurgical intensive care unit, particularly for head-injury cases.
36
 Propofol is known 
to decrease CBF while preserving brain flow-metabolism coupling and act as a global 
central nervous system depressant.
35
 It has been shown that a typical anesthetic induction 
dose of propofol reduces blood pressure by approximately 30% resulting from a decrease 
in sympathetic activity, direct vasodilation, and myocardial depression.
37, 38
 When the 
anesthetic was switched from isoflurane to propofol, there was a statistically significant 
increase in HR, suggesting that decrease in peripheral vascular resistance induced by 
propofol was partially compensated by an increase in heart rate.
35
 The use of a 
background propofol infusion with Xe and N2O is due to the fact that both anesthetic 
cannot induce reliable anesthesia on their own.  
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 Although quantitative and mobile, a limitation with the TR-NIR technique is the 
need to inject a bolus of ICG every time CBF is measured. However, this is a minimally 
invasive procedure since ICG is injected into a peripheral vein and the arterial ICG time-
concentration curve can be measured noninvasively by pulse dye densitometry. 
Moreover, Verdecchia et al have shown that TR-NIR can be combined with diffuse 
correlation spectroscopy (DCS) to provide almost ‘continuous’ quantitative assessment of 
CBF and CMRO2.
39
 DCS is used to measure changes in CBF and CMRO2 from their 
values at baseline (or calibration) which, in turn, are measured using TR-NIR with ICG 
injection as discussed in this report. With this approach, only infrequent injections of ICG 
is needed to calibrate the pseudo-continuous measurement of changes into absolute values 
of CBF and CMRO2. Piglets were studied because signal contamination from extra-
cerebral tissue is relatively low, which enables the measured TPSFs to be characterized 
by the diffusion equation for a homogeneous semi-infinite geometry. 
 In conclusion, we have shown the ability of TR-NIR technique to measure 
absolute CBF during HT and investigated the cerebral metabolic activity under different 
anesthetics at different temperature in a normoxia animal model. Both CBF and CMRO2 
decreased by decreasing the temperature but the OEF remained unchanged which 
indicates a tight coupling of flow and metabolism under different anesthetics over the 
mild HT temperature range (38°-33°C) which might not be the case in the ischemic brain. 
Furthermore, rewarming is a critical phase of therapeutic HT to monitor for oxidative 
stress.
9, 40
 Rapid rewarming of the injured brain commonly leads to a mismatch between 
cerebral metabolism and perfusion
9
 and can cause in rebound intracranial pressure 
elevations
41
, cerebral venous desaturation
40
, and brain ischemia. It is suggested that 
controlling the rewarming rate as low as 0.1-0.4°C/hour is preferred to reduce the 
neurological risks.
42
 Therefore, predicting and managing possible systemic side effects of 
rewarming is also important for guaranteeing HT efficacy. As the next step, we will be 
investigating the OEF changes before, during and after HT in hypoxic-ischemic neonatal 
pigs.  
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Chapter 5 
Conclusions and Future Work 
5. Summary of Stated Objectives 
 The introduction chapter of this thesis discussed the importance of selective brain 
cooling to maximize the neuroprotictive effects of mild hypothermia and avoid adverse 
complications from whole body cooling. The primary objective of this research, therefore, 
was to develop a nasopharyngeal cooling approach which targets only the brain tissue not 
only capable of inducing fast cooling but also can maintain the target temperature over 
extended period of time (Chapter 2). However, a proper evaluation of brain cooling 
requires accurate measurement of the brain temperature locally instead of relying on 
inference from core temperature. For this purpose, a non-invasive technique was 
developed to measure brain temperature during hypothermia as described in Chapter 3. 
As discussed in detail in the previous chapters, one of the important mechanisms of 
hypothermia-induced neuroprotection is due to suppression of brain metabolism, and it is 
important to determine whether the combination of anesthesia and hypothermia alters 
flow-metabolism coupling. In Chapter 4, we examined the effect of hypothermia on flow-
metabolism coupling under different anesthetic regimes and temperatures.  
 The next section of this chapter will summarized each of these developments 
within the context of the objectives presented in Chapter 1. Following this, future 
directions of this research will be discussed.  
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5.1 Whole-Body and Selective Brain Cooling Approach 
(i) Selective Brain Cooling Using Nasopharyngeal Method 
 Cooling the nasopharynx may offer the capability to cool the brain selectively by 
cooling inflowing blood in both internal carotid arteries (ICAs) via counter-current heat 
exchange mechanism with the neighboring cavernous sinuses which collect cold venous 
blood from the mucosal linings of the nasal cavities. Furthermore, cerebrospinal fluid 
chilled at the basal cistern cools the whole brain through the cerebrospinal fluid (CSF) 
circulation. We have demonstrated an effective, safe and simple method of 
nasopharyngeal cooling by continuously blowing room temperature or humidified cold air 
at different flow rates into the nostrils of normal new-born piglets with developed thermal 
regulation (Chapter 2). Effective brain cooling in new-born piglets was achieved with a 
median cooling rate of 1.7 ± 0.9°C/h by setting the flow rate of room temperature air to 3-
4 L.min
-1
. Results of comparing different temperatures and flow rates in the 
nasopharyngeal cooling approach reveal that the brain temperature could be reduced 
rapidly at a rate of 5.6 ± 1.1°C/h by increasing air flow rate to 14-15 L.min
-1
 while 
keeping air at a cold temperature (≈-8°C). It was also possible to maintain brain 
temperature within ± 0.45°C for an hour once it reached the target temperature of 33-
34
o
C by decreasing the flow rate to 0.5-1.5 L.min
-1
. 
 
 
 In new-born piglets, when the brain was kept at the target temperature, rectal 
temperature continued to drop until it reached the brain temperature. This decline in rectal 
temperature despite a constant brain temperature could be due to the imbalance between 
heat production in the rest of the body and the heat lost through cold air-flow in nasal 
cavities. It was possible to maintain the brain-body temperature gradient (≈-3°C) during 
nasopharyngeal cooling by using colder air temperature and higher flow rate in older 
heavier than new-born pigs, i.e. 16 kg versus 2-3 kg and by using heating blanket/sheets 
to cover the whole body (Appendix B). The nasopharyngeal air cooling method can be 
easily implemented in hospitals and even on ambulances to selectively cool down the 
brain to ameliorate brain damage from hypoxia-ischemia in newborns and traumatic brain 
injuries in children and adults and in resuscitated cardiac arrest patients and in stroke 
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patients. This study was the first step in developing a reliable, safe and efficient cooling 
device for future clinical trials on the neuroprotective effects of mild hypothermia and 
will be of benefit to different patient populations. 
(ii) Whole-Body Cooling with Mechanical Ventilation of Cold 
Air via the Respiratory Tract 
 Based on considerations of their anatomical architecture and intimate contact with 
the entire cardiac output, lungs and the pulmonary circulation may act as in-vivo 
exchanger by transferring heat from the pulmonary blood to cold air introduced by 
ventilation into alveolar spaces in the lungs and then to the environment. Experimental 
results described in Appendix A, show that the brain temperature fell from 38.3 ± 0.3°C 
to 36.5 ± 0.6°C during three hours of ‘pulmonary’ cooling which corresponded to a mean 
cooling rate of 0.6 ± 0.1°C/h. The relatively small cooling rate observed in this study 
could be explained by a combination of reasons. Using a single endotracheal tube for both 
inspiration and expiration allows rapid warming of the incoming cold air by 
countercurrent heat exchange between inspired and expired gas in the endotracheal tube 
and upper airways before reaching the alveoli. The heat exchange between inspiratory 
and expiratory gas is a powerful mechanism for thermal isolation of alveolar gas and 
normally prevents penetration of cold environmental gas beyond 10-15 cm in the upper 
airway.
1
 Another drawback of pulmonary cooling is adverse side effects associated with 
whole body cooling as discussed in “Introduction”.  
5.2 Monitoring of Brain Temperature by TR-NIRS 
Technique  
 Wide clinical adaptation of mild hypothermia has been hampered by the lack of a 
reliable noninvasive method for monitoring local brain temperature to adjust cooling and 
rewarming rate. The commonly used core (rectal) temperature is a poor substitute as it 
has been shown to not always reflect brain temperature. Since the brain is composed of 
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80-90% water and its absorption of near infrared (NIR) light depends on temperature, the 
goal of this work was to develop an optical technique for measuring brain temperature by 
exploiting the temperature-dependency of water absorption of NIR light.  
 Specifically, we developed a method based on TR-NIRS to measure temperature 
continuously and noninvasively in tissue-mimicking phantoms (in-vitro) and deep brain 
tissue (in-vivo) during heating and cooling. For deep brain tissue temperature monitoring, 
experiments were conducted on newborn piglets wherein hypothermia was induced by 
packing the whole body in ice packs. Brain temperature was concomitantly measured by 
TR-NIRS and by an invasive thermometer. Our proposed TR-NIRS method was able to 
measure the temperature of tissue-mimicking phantoms and brain tissues with a 
correlation of 0.82 and 0.66 to temperature measured with a thermometer, respectively. 
The mean difference between the TR-NIRS and thermometer measurements was 0.15 ± 
1.1°C for the in-vitro experiments and 0.5 ± 1.6°C for the in-vivo measurements. 
5.3 Coupling of Cerebral Blood Flow and Oxygen 
Consumption During HT Under Different 
Anaesthetics Measured with a TR-NIRS Technique 
 As discussed in detail in the introduction chapter of this thesis, neuroprotective 
effects of HT is partly due to suppression of cerebral metabolism to match the demand of 
oxygen with supply so as to maintain the tissue oxygenation status. In the brain, tissue 
oxidation status is reflected by the OEF, which is the ratio of CMRO2 to CBF, as this is 
tightly controlled to be around 33% under normal conditions. Imbalance in supply and 
demand of oxygen, or oxidative stress, whatever the cause will lead to an increase in 
OEF. The focus of our work in this project was, therefore, two-fold: first, to evaluate the 
ability of the TR-NIR technique to measure CMRO2 and CBF in piglet brain and second, 
to investigate the effects of hypothermia and different anesthetic regimes on OEF in 
normal piglets.   
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 A bolus-tracking method, using ICG as a flow tracer with TR-NIR technique, was 
used to measure CBF and CMRO2 in newborn piglets in which brain temperature was 
lowered from ≈38°C to ~33°C under three anesthetic regimes, i.e., Isoflurane, 
Propofol/Nitrous-Oxide (N2O) and Propofol/Xenon (Xe)40-50%. Results demonstrate that 
TR-NIR can measure CBF with reasonable accuracy as compared to the reference CT 
Perfusion method
2
 and is sensitive to flow changes induced by either hypothermia or 
anesthetic drugs. There was a good agreement between CBF obtained with the two 
methods (R
2=0.84, ∆(mean difference between CT Perfusion and TR-NIR)=5.84 ml. min-
1
.100 g
-1
), demonstrating the ability of the TR-NIR technique to non-invasively measure 
absolute CBF in-vivo during HT. The TR-NIR technique reveals that CBF decreases from 
54.3 ± 5.4 ml. min
-1
.100 g
-1
, at normothermia (brain temperature ~38°C), to 33.8 ± 0.9 
ml. min
-1
.100 g
-1
 at a brain temperature of ~32°C during HT treatment under isoflurane 
anesthesia. Both CBF and CMRO2 were affected by changing the anesthetic regime. 
However, the ratio of CMRO2 to CBF (or OEF) remained unchanged at around 33% 
which indicates, as expected, different anesthetics over the mild hypothermia temperature 
range does not cause oxidative stress in the brain such that the tight coupling of flow and 
metabolism is maintained in the resulting normoxia condition.  
5.4 Future Work  
(i) Advances in the Selective Brain Cooling Approach 
 Our in-vivo experimental studies have demonstrated the feasibility of selective 
brain cooling using the nasopharyngeal air cooling approach. One important aspect which 
was not tested in our experiments is controlling the rewarming rate. As discussed in detail 
in the introduction chapter, rewarming is a critical phase of therapeutic hypothermia in 
that too fast a rewarming rate will lead to oxidative stress and subsequent brain damage. 
Thus, understanding, predicting, and managing possible adverse effects of rewarming is 
important for guaranteeing hypothermia efficacy. To better control cooling and 
rewarming rates, further development required include developing and testing a prototype 
device with a computer-controlled feedback system to automatically adjust settings of 
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cold air temperature and flow rate to arrive at desired brain temperature or cooling or 
rewarming rates.     
 Before the nasopharyngeal air cooling method can be used in clinical trials, more 
experimental studies are necessary to evaluate the efficiency of the device and 
reproducibility of the results in large animal models of normal and injured brain. In 
addition, patient safety is a critical aspect of the evaluation. Although it is unlikely that air 
at subzero temperature and high flow rate will induce freezing damage to the mucosa and 
embedded blood vessels and nerves of the nasal cavity, histological analyses of the 
excised tissue from the nasal cavities of animals studied should be performed to assess for 
tissue damages. 
(ii) Improvement in Temperature Prediction 
 Compared to discrete-wavelength approaches, access to a continuous NIR 
absorption spectrum offers two important advantages i.e., better chromophore 
identification and improved concentration quantification. These features are particularly 
useful when chromphore spectra are used to predict deep tissue temperature. To obtain 
chromophore spectra, broadband optical spectroscopy will be made available within the 
existing TR system through the incorporation of a broadband spectrometer. The intensity 
spectra from broad band spectroscopy will be calibrated by the scattering and absorption 
coefficients measured by time-resolved (TR) method at a number of wavelengths to 
provide an absolute scattering and an absolute absorption spectrum of the tissue from 
600-1050nm. From the absorption spectrum, the absolute chromophore concentrations 
along with water spectral information within the tissue can be determined. Furthermore, 
as a water molecule hydrogen bonds to other molecules its absorption changes by red-
shifting and broadening. As a result, a bound water correction should be used to account 
for the shifting and broadening of the water spectra to improve temperature prediction 
3, 4
.  
 The major challenge in adapting this technique to adult patients is the significant 
signal contamination from superficial tissues. This is not a concern in neonatal 
121 
 
applications, where the scalp and skull is negligible and it is reasonable to assume that all 
the collected light has traveled through brain tissue. However, in the adult subjects, the 
scalp, skull, and cerebral spinal fluid surrounding the brain can contribute significantly to 
absorption. In this case, it becomes very difficult to measure absolute concentrations of 
cerebral chromophores. It has previously been demonstrated that the depth sensitivity of 
the NIR signal is proportional to the distance separating emitter and detector.
5
 This multi-
distance, or depth-resolved approach allows the separation of information into superficial 
and deep components on the basis that light penetration increases with source-detector 
distance. Consequently, by collecting information at multiple distances simultaneously, it 
is possible to separate out information in terms of tissue layers, using an optical 
reconstruction approach.
6
 
(iii) Investigate the Effects of HT/Xe Administration on Flow-
Metabolism Coupling in a Hypoxic-Ischemic Model Using 
TR-NIR  
 We have already shown that under normoxic conditions, mild hypothermia with 
different anesthetics preserved flow-metabolism coupling resulting in constant oxygen 
extraction fraction at ~33%. As the next step, it is necessary to investigate using piglet 
hypoxia-ischemia models whether under oxidative stress, the neuroprotective effect of 
mild hypothermia will preserve tight coupling of flow and metabolism as observed in 
normoxia. Since TR-NIR is safe and measurements can be obtained at the bedside in only 
a few minutes, it is believed that this technique could assist in monitoring of 
neuroprotection in the neonatal intensive care unit during combination therapies of 
hypothermia and Xe administration.  
5.5 Conclusion 
 In summary, the significant findings in this thesis include: 
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1) Nasopharyngeal air cooling by spraying humidified and cold air into nasal cavities 
is an effective, safe and simple method to selectively reduce and maintain brain 
temperature, with no major disturbances in physiological variables or adverse 
effects. 
2) The developed TR-NIRS temperature measurement technique is able to measure 
brain temperature non-invasively in neonatal pig to an accuracy of 0.5 ± 1.6°C. 
3) Both cerebral metabolic activity (CMRO2) and CBF can be measured by TR-
NIRS. Moreover, mild hypothermia under different anesthetics preserves the 
coupling between CBF and CMRO2 in normoxia. 
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Appendix A 
Brain Cooling With Ventilation of Cold Air Over 
Respiratory Tract: Experimental and Numerical 
study 
Appendix A is adapted from the work entitled “Brain Cooling With Ventilation of Cold 
Air Over Respiratory Tract: an Experimental and Numerical study”, by M Fazel 
Bakhsheshi, EE Stewart, H Vafadar, L Keenliside and TY Lee, submitted to the Journal 
of International Communications in Heat and Mass Transfer. The focus of this paper is to 
investigate the effects of cold gas (O2-Air) introduced through an endotracheal tube on 
brain temperature.   
A. Introduction 
 From the neonatal asphyxia studies, only one in six children benefit from this 
treatment
1
, and the rate of death and disabilities remains high in these cooled infants.
1
 
Xenon (Xe) is a rare noble gas with anesthetic properties, also showing a great promise as 
a neuroprotectant.
2-5
 Recent investigation showed that inhalation of Xe had an additive 
neuroprotective effect with HT; shown to increase neuroprotection from ~35% 
(hypothermia only) to ~70% when hypothermia was combined with 50% inhaled Xe gas.
6
  
 Based on anatomical features and effectiveness of pulmonary architecture and its 
intimate contact with the entire cardiac output, lung and pulmonary circulation may act as 
in vivo heat exchanger, such that heat can move from the blood to alveolar space and then 
to the environment.
7-10
 In the present study, we evaluate the efficiency of pulmonary and 
brain cooling with and without xenon administration over respiratory tract. These data are 
difficult to acquire in clinical setting, as the cost and scarcity of Xe, as well as accuracy of 
invasive measurements of brain tissue temperature cannot be easily justified. Therefore, 
we took advantage of advances in the numerical modeling of heat and water vapor 
transport in tissues and used computational approach to predict temperature distribution 
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in the brain during pulmonary cooling using two different gas mixtures, i.e., O2-Air (1:2) 
and O2-Xe (1:2). In addition, we have investigated the effect of some physiological 
parameters across respiratory tract through numerical simulation. Following numerical 
simulations, we examined the theoretical predictions in anesthetized piglets to investigate 
the effects of cold gas (O2-Air) introduced through an endotracheal tube on brain 
temperature, and we concurrently measured physiological parameters during whole 
experiments. 
A.1 Materials and Methods 
A.1.1 Theoretical Model 
 Analysis of heat and water transport process in the respiratory tract is a difficult 
task because the flow patterns inside this area are rather complex. For simplicity, the 
airway can be idealized as a long, right circular cylinder structure
11
, which simplifies the 
theoretical analysis (Figure A.1). Based on the well-known Pennes bioheat transfer 
equation
12
, balance of the energy in the tissue between heat conduction through cellular 
tissue portion, heat convection by flow of blood and the heat production due to cellular 
metabolism results as follows:  
   b b b
T
C k T c T T Q
t
 

    

 (A.1) 
where ρ(kg.m-3), C(J.kg-1.ºC-1), and k(w.m-1.ºC-1) are the density, specific heat, and 
thermal conductivity of tissue, T(ºC)  is the local tissue temperature, and t(s) is the time, 
ωb(kg.m
-3
.s
-1
) is the volumetric blood perfusion rate, Cb(J.kg
-1
.ºC
-1
)  is the specific heat of 
blood, Tb(ºC) is the supplying arterial blood temperature and Q(W.m
-3
) is the metabolic 
heat generation rate.  
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Figure A.1. Schematic diagram of the airway model. 
 
 At the mucous-air interface (r = a), the boundary condition for the heat transfer is 
generally composed of two parts, i.e., convection and evaporation. At the entrance of the 
nasal cavity (x = 0), the continuity of heat flux is imposed as a convective boundary 
condition and also at both deep tissue (r = b) and the end of human respiratory tract (x = 
L) heat flux is assumed to approach zero. The boundary conditions can be written as 
follows
11
:  
   * *fA m m
T
k h T T 0.001HM P P
r


   

                                  r = a (A.2) 
0
T
r



                                                                                         r = b (A.3) 
 in
T
k h T T
x

 

                                                                       x = 0 (A.4) 
0
T
x



                                                                                         x = L (A.5) 
where Tin(ºC) is the breathing air temperature, h' is the apparent heat convection 
coefficient between the tissue and the breathing air , h(W.m
-2
.ºC
-1
) is the heat convection 
coefficient between the mucosal surface and the flowing airstream for each air stream, 
i.e., O2-Air and O2-Xe
13, 14
.  is the relative humidity of flowing air from ventilator; 
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H(J.kg
-1
) is the latent heat of water vapor; Mm (kg.s
-1
.m
-2
.Pa
-1
) is water penetrative 
coefficient in mucosal surface; P
*
f(Pa) is the saturated vapor pressure at breathing air 
temperature and p
*
m(Pa) is the saturated vapor pressure at tissue temperature which can 
be calculated as following
15
: 
 * 2 31 2 3 4 5 6( )
c
ln P c c T c T c T c ln T
T
       (A.6) 
where ln is the natural logarithm. In the respiratory tract, the energy balance equation for 
the air can be defined as
11
:  
 
 * *
1000
am tA A
A A A
HM P PT T S
C u h T T
t x A


               
 (A.7) 
where CA(J.kg
-1
.ºC
-1
) and A(kg.m
-3
) are the specific heat and density of the air at each 
condition; S(m
2
) and A(m
2
) are the local airway cross-section and perimeter; u(m/s) is the 
mean longitudinal air velocity. The air temperature gradients in the axial direction are 
usually much smaller than that in the radial direction. Correspondingly, the axial 
conduction is neglected here for simplicity. During the inspiration and expiratory phases 
of the breathing cycle, the axial inlet (x = 0) boundary condition is considered as the 
ventilator air temperature (TA = Tin) and the heat flux is assumed to approach zero (
0AT x   ) at the end of the human respiratory tract (x = L). The energy balance for the 
blood and tissue is defined by conduction in the tissue and convection in the blood as 
follows: 
   
   
, , , ,
, , ,
( )
m m
bt m b
T x a t T x b t
k h T x b t T x t
b a

   
 (A.8) 
Where hbt is heat convection coefficient between blood and tissue, a(m) is the radius of 
respiratory tract, b(m) is the external radius of calculation domain and k(W.m
-1
.ºC
-1
)  is 
the thermal conductivity of tissue. Numerical simulation was applied to solve above 
equations and calculate the thermal impact of inhaled cold air to the mucous membrane 
and blood temperature which therefore used to predict the brain tissue temperature using 
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the mathematical model of temperature distribution in Equation (A.1) for the brain tissue 
parameters. For the thermal boundary condition, the heat flux is assumed to approach 
zero at the outer boundaries of the brain tissue.
16
 The initial condition is a steady-state 
temperature uniform distribution at thermoneutral conditions (T = 38.5°C). The typical 
values for tissue and air properties for following numerical calculation are presented in 
Table A.1.
12, 15, 17, 18
 
Table A.1: Base set of parameters used in heat sink thermal model.
12, 15, 17, 18
 
Symbol Unit Value 
ρB,m (kg.m
-3
) 1030 
Cb (J.kg
-1
.ºC
-1
) 3643 
Qm (W.m
-3
) 420 
QB (W.m
-3
) 5370 
Mm (kg.s
-1
.m
-2
.pa
-1
) 1.3 e-6 
hbt (W.m
-2
.ºC
-1
) 10000 
h
´
 (W.m
-2
.ºC
-1
) 50 
H (J.kg
-1
) 2431 
a (m) 0.005 
b (m) 0.025 
L (m) 0.3 
u (m.s
-1
) 0.68 
Tin (ºc) 5 
k (W.m
-1
.ºC
-1
) 0.5 
A (m
2
) 7.85 e-5 
S (m) 0.032 
ωb 
(kg.m
-3
.s
-1
), 
(ml.100g
-1
.min
-1
) 
3-11,                  
(15-66) 
c1, c2, c3,   
c4, c5, c6  
-5800, 1.4, -0.05, 
4.2 e-5, 7.8 e-5, 6.5 
 
 
0.3 
A.1.2 Animals Preparation and Experimental Procedure 
 Experiments were conducted on nine piglets. All animal experiments were 
approved by the Animal Use Subcommittee of the Canadian Council on Animal Care at 
the University of Western Ontario. Newborn Duroc cross piglets were obtained from a 
local supplier on the morning of the experiment. Piglets were anesthetized with 1-2% 
isoflurane (3-4% during preparatory surgery). A tracheotomy was performed and the 
piglet was ventilated with a volume-controlled mechanical ventilator to deliver O2 and 
medical air mixture with the following variable values: tidal volume 10 mL/kg, frequency 
35-45/min and fractional concentration of inspired O2 (FIO2) 1.0. A femoral artery was 
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catheterized to monitor HR and MAP and to intermittently collect arterial blood samples 
for gas (paCO2, paO2), pH and glucose analysis. Arterial CO2 tension (paCO2) was 
monitored throughout the experiment, either directly by blood gas measurements or by 
the end-tidal CO2 tension, and maintained at normocapnia between 37-42 mmHg by 
adjusting the breathing rate and volume. Arterial oxygen tension (paO2) was maintained at 
a level between 90-130 mmHg by adjusting the ratio of O2 to medical air. Blood glucose 
was monitored intermittently and if it fell below 4.5 mmol/L, a 1-2 ml infusion of 25% 
glucose solution was administered intravenously. After surgery, piglets were maintained 
on 1-2% isoflurane at normothermia using heated water blanket to maintain rectal 
temperature between 37.5-38.5°C. Piglets were randomized in two groups, control group 
in which piglets were just covered with blankets to maintain their body temperature 
(Group I, n = 4); and pulmonary cooling group in which heat loss through respiratory 
airways occur by cooling of inhalation gases (Tin ≈ -3 ± 3°C) right before going to trachea 
via shortened endotracheal tube while their body were covered with blankets during 
whole experiments (Group II, n = 5). Rectal temperature was recorded from a rectal probe 
inserted to 3-4 cm from the anal margin. Deep brain temperature was also measured 
continuously with a thermocouple probe. A hole was made in the skull with a Dremel 
tool. The needle thermocouple probe was inserted laterally through the skull into the brain 
to a depth of 2 cm vertical from the brain surface and 0.5 cm posterior to the bregma. 
Each experiment was completed within 5 hours. After the last measurement, the animals 
were sacrificed using potassium chloride IV (1-2 ml/kg) while on 5% inhaled isoflurane. 
The ambient temperature of the animal libratory was maintained relatively constant at 22 
± 0.5°C. 
A.1.3 Pulmonary Cooling Approach 
 Cold inspired air was generated by circulating inhalation air, delivered from 
ventilator, through coiled heat exchanger immersed completely in water bath before 
delivering to piglet, as shown in Figure A.2. Before starting the cooling process, the 
cooling unit which control the temperature of water bath was set to -20°C with a 
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temperature stability of ±0.05°C over 30-45 min; settings were kept the same during the 
entire experiment. The inhaled temperature (-3 ± 3°C) was monitored between the air 
cooling system and endotracheal tube. During expiration, air leaving the lungs at body 
temperature is cooled as it passes along the respiratory tract by mixing with cold inspired 
air. 
 
 
 
 
 
Figure A.2. Schematic representation of the cooling circuit used for pulmonary cooling. 
A.1.4 Statistical Analysis 
 SPSS 17.0.0 (SPSS, Inc, Chicago, IL) was used for all statistical analyses. 
Normality of the distribution of the measurements was verified using Kolmogorov-
Smirnov (KS) test. Comparisons between time-based measurements within groups were 
performed by Friedman test. Man Whitney U test was used to determine statistical 
differences of cooling rates as a function of treatment group. Statistical significance was 
based on p-value < 0.05. All data are presented as mean ± SD unless otherwise noteds 
A.2 Results 
 Animal experiments were conducted on nine piglets (five females and four males), 
with an average age of 4.5 ± 1.5 days old and an average weight of 3.7 ± 1.2kg. Table A.2 
present a summary for the averaged physiologic parameters of the piglets (MAP, HR and 
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paCO2) in each group. The results presented in Table A.2 demonstrate that HR and MAP 
dropped slowly through nasopharyngeal cooling approach. The results of arterial blood 
gas analysis were corrected for temperature. No significant changes were found between 
two groups with respect to HR, MAP, paO2, paCO2, tHb, or pH. 
Table A.2: Physiological parameters measured at different groups. 
 
 Baseline Cooling 
Variable  1-60min 0.5hr 1.5hr 3hr 
MAP  
(mmHg) 
Group I 55 ± 7 52 ± 6 54± 7 53± 5 
Group II  55 ± 10 56  ± 10 52 ± 7 47± 7 
HR (bpm) 
Group I 162 ± 16 163 ± 15 162 ± 16 157 ± 18 
Group II 152 ± 38   156 ± 51    155 ± 40    141 ± 31 
paCO2 
(mmHg) 
Group I 39 ± 3 40 ± 3 39 ± 3 39 ± 2 
Group II 42 ± 3 41 ± 2 37 ± 2 41 ± 2 
paO2 
(mmHg) 
Group I 131 ± 44 133 ± 32 125 ± 30 142 ± 24 
Group II 127 ± 40 132 ± 35 128 ± 30 127 ± 34 
Figure A.3 (a) displays the maximum absolute cooling rates as monitored in the 
brain obtained from groups I and II as well as theoretical models for O2-air (1:2) and O2-
Xe(1:2) conditions. In animal experiments, mean brain cooling rate was significantly 
greater (p<0.05) in pulmonary group i.e., (Group II) as compared with control group 
(Group I). In the control group, both rectal and brain temperatures did not drop more than 
0.3 ± 0.1°C. Figure A.3-b displays the measurements of the brain temperature as a 
function of time during ventilation of cold O2-air (1:2) in both experimental and 
theoretical models. In animal experiments, following the baseline (38.3 ± 0.3°C), the 
brain temperature reached to 36.5 ± 0.6°C which corresponded to a mean cooling rate of 
0.6 ± 0.1°C/h, respectively. Average temperature difference between rectal and brain was 
0.5 ± 0.1°C during whole animal experiments. Numerical simulations for two different air 
conditions (i.e., O2-Air and O2-Xe) during pulmonary cooling show that brain 
temperature drop to 35.1 ± 0.4°C and 35.7 ± 0.5°C which corresponded to a mean cooling 
rate of 0.98 ± 0.35°C/h and 0.8 ± 0.3°C/h, respectively (Figure A.3-a). Average 
temperature difference between two air streams was 0.2±0.1°C over three hour's 
simulation. Numerical simulations show no significant differences between two different 
inhaled conditions with respect of cooling rate.  
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        (a) 
 
           (b) 
Figure A.3. (a) Maximum cooling rate for brain as a function of groups and theoretical predictions; 
(b) Brain temperature measurements over time for experimental and theoretical model.  
   
 In addition, numerical calculations were performed to investigate the effect of 
some physiological parameters such as blood perfusion, thermal conductivity, metabolic 
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rate and air velocity across respiratory tract as displayed in Figure A.5 (a-d), respectively. 
According to the numerical results, decreasing the perfusion, metabolic rate and 
increasing the thermal conductivity and flowing air velocity is accelerated cooling in 
respiratory tract and brain tissue accordingly. For simplicity, all tests for respiratory tract 
in order to investigate the effect of different parameters on temperature profiles have been 
carried out for only an hour. 
 
    (a) 
 
 
     (b) 
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       (c) 
 
Figure A.4. Effects of (a) blood perfusion level; (b) air velocity, and (c) metabolic rate across 
respiratory tract response on blood temperature. Calculation were carried out with thermal 
conductivity k = 0.5 w.m
-1
.ºC
-1
, flowing air temperature Tin = 5ºC, metabolic rate Qm = 420 w.m
-3
, 
local mean longitudinal air velocity V = 30 cm
3
.s
-1
 and blood perfusion rate ωb = 50 ml. min 
-1
.100 g 
-
1 
as a default values for each simulations. 
A.3 Discussions 
 There are different methods of cooling which utilize different physiological 
mechanisms of convective and conductive heat loss. Since the entire cardiac output 
passes through the pulmonary capillary network and the heat of the body can be 
transferred to the environment via the vast alveolar surface, the lung can serve as a core 
heat exchanger. As a consequence of conduction, convection, and water evaporation, heat 
is lost from the trachea and respiratory tract, and the temperature of these surfaces falls 
below body temperature and this eventually cooled down the whole body.
7-10
 Forman et 
al. and Shaffer et al. have demonstrated the feasibility of liquid ventilation to induce 
hypothermia.
8, 9
 In their methods, liquid ventilation was used to induce hypothermia with 
the cooling rate of 4.8-8.4°C/h, in which perfluorocarbon (PFC) liquids of 20-30°C were 
tidally exchanged from the lung by an extracorporeal circuit. The problem with their 
method is associated with the safety profile of its coolant. PFCs are powerful greenhouse 
gases and deplete the ozone layer and are listed as toxic substances under the Canadian 
Environmental Protection Act (CEPA).
19
 Another safety concern is the risk of coolant 
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aspiration which might cause lung damage over prolonged periods since neural protection 
therapy may involve mild hypothermia being maintained for period of 72 hours.
20
 
Insufflations of cold gas have also been studied; however, sufficient cooling rates can 
only be achieved with very cold inhalation.
7, 10
  
 Our study shows that the brain temperature of those animals breathing cold O2-Air 
fell to 36.5 ± 0.6°C in three hours without significant hemodynamic deterioration which 
corresponded to a mean cooling rate of 0.6 ± 0.1°C/h. Relatively small cooling rate in this 
study could be explained by combination of different reasons. Eemploying single 
endotracheal tube for both of inspiratory and expiratory gas increases the efficiency of the 
heating as cold air warmed rapidly by countercurrent heat exchange between inspired and 
expired gas in the endotracheal tube and upper airways before reaching to the alveoli. The 
heat exchange in the upper airway is a powerful mechanism for thermal insulation of 
alveolar gas and normally prevents penetration of cold environmental gas beyond 10-15 
cm.
21
 The potential for increasing evaporative heat loss from the respiratory tract is also 
limited by the detrimental effects of prolonged ventilation with dry gas and should not be 
used clinically used to lower temperature.
22
  
 In the present study, a computational program was written with MATLAB to 
calculate and analyze the transient temperature distribution across the respiratory tract 
and within the brain using control-volume finite-difference method.
23
 We also show how 
changes of different parameters can affect the temperature profiles in the respiratory tract. 
The heat exchange across the respiratory tract depends on the airflow rate, the 
temperature of expiratory and the inspiratory gas, and its thermal properties. Figure A.5 
(a) shows the temperature change for three different blood perfusion rates. It can be seen 
that larger blood perfusion tends to prevent the biological tissues from cooling. This result 
can explain the fact that newborns, whose blood perfusion is generally lower, are easier to 
be cooled than adults. As Figure A.5 (b) displays, higher air velocity yields greater 
cooling effects. Figure A.5(c) also shows the temperature responses with different 
metabolic rates. Clearly, the cooling rate can be increased with lower metabolic rate.  
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 They are several limitations in our numerical study that should be pointed out. For 
example, more complex geometrical and physiological parameters of the respiratory 
system may be incorporated for a more comprehensive estimation of brain tissue 
temperature during pulmonary cooling. In this study, some brain and respiratory thermal 
parameters, including air velocity and the metabolic rate are assumed to be constant in the 
tissue due to relatively small change in temperature. However, It has been shown that 
reducing brain tissue temperature from 37 to 34ºC reduces the metabolic rate by about 
25%. Piglets were studied because they are commonly used animal model of newborn 
human neurology. 
 The effect of different thermal properties of respiratory gas on brain cooling was 
examined using two different air streams with theoretical model. Although the thermal 
conductivity and specific heat capacity of air are 5-6 times more than Xe, but the heat 
exchange via the respiratory tract and brain cooling rate was still very smile by 
substituting Air with Xe. The thermal properties of O2-Air and O2-Xe are compared in 
Table A.3.
24
 Numerical simulations show no significant differences between two different 
inhaled conditions with respect of cooling rate with average temperature difference of 0.2 
± 0.1°C over three hours simulation. Neuroprotective effect of hypothermia has been 
linked to how rapidly cooling is initiated, how quickly the brain is cooled, the etiology of 
injury and the extent of tissue that reaches the therapeutic hypothermic zone.
25, 26
 
Therefore, the results of this work suggest that simultaneous administration of HT and Xe 
with pulmonary cooling technique is inefficient to induced rapid cooling. 
Table A.3: Comparison of some physical properties of O2-Air and O2-
Xe at normal atmospheric pressure.
24
 
 
 O2-Air(1:2) O2-Xe(1:2) 
Density (kg.m
-3
) 1.5 4.014 
Specific Heat (J.kg
-1
.ºC
-1
) 900 246 
Thermal 
Conductivity 
(W.m
-1
.ºC
-1
) 0.021 0.010 
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Appendix B 
Comparison of Selective Brain Cooling in Juvenile 
and Newborn Piglets Using a Nasopharyngeal 
Method  
B.1  Materials and Methods 
 Animals were anesthetized with 1-2% isoflurane. A tracheotomy was performed 
and the animal was ventilated with a volume-controlled mechanical ventilator to deliver 
Oxygen (O2) and medical air mixture. A femoral artery was catheterized to monitor HR 
and MAP and to intermittently collect arterial blood samples for gas (paCO2, paO2), pH 
and glucose analysis. Animals were randomized into the different groups:  
I. control group in which whole body of piglet was covered with blankets, (n=3);  
II. nasopharyngeal cooling group in which hypothermia was induced by directing 
humidified and cooled medical air (≈-8°C) at the flow rate of 14-15 Liter.min-1 into the 
nasal cavities via catheters while core body temperature was maintained within 35.5-
36.5°C using heating blanket and hot water gloves by iteratively turning heating blanket 
"on" and "off" at;  
II-a. New-born piglets with an average age 1-2 days old and an average weight of ≈1-
2kg, (n=3) and;  
II-b. Juvenile pigs with an average age of 3 weeks old and an average weight of 
≈16kg, (n=2);  
Rectal temperature was recorded from a rectal probe inserted to 3-4 cm from the anal 
margin. Brain temperature measured far away from nasal cavities (7-8cm) to make sure to 
achieve whole brain cooling at depth of 2 cm vertical from the brain surface and 1.5 cm 
posterior to the bregma. 
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B.2 Results 
 Table B.1 presents a summary for the averaged physiologic parameters for each 
group related to Figure B.1. Both the heart rate (HR) and mean arterial blood pressure 
(MAP) dropped slowly through nasopharyngeal cooling approach in the new-born piglets, 
i.e. group II-a. No significant changes were found in the juvenile pig, i.e. group II-b, with 
respect to HR or MAP.  
Table B.1. Physiological parameters measured at each group. 
   Baseline Cooling 
   1-60min 30 min 1 hr 2 hr 3 hr 
MAP  
(mmHg) 
Control 36 ± 7 34 ± 6 36 ± 7 36 ± 7 36 ± 7 
Nasal 
Cooling 
New-born 
piglet 
46 ± 2 44 ± 2 44 ± 5 37 ± 3 36 ± 5 
Juvenile 
pig 
52 ±3 53 ± 5 55 ± 4 50 ± 5 52 ± 4 
HR 
(bpm) 
Control 162 ± 16 
163 ± 
15 
162 ± 
16 
162 ± 
16 
162 ± 
16 
Nasal 
Cooling 
New-born 
piglet 
164 ± 15 
145 ± 
16 
133± 
19 
133± 
19 
133± 
19 
Juvenile 
pig 
181 ± 9 
176 ± 
13 
165± 
19 
168± 
14 
170± 
17 
 Figure B.1 displays the maximum absolute cooling rates achieved at each group as 
monitored in the brain and core rectal compartment. Results of comparing both groups in 
the nasopharyngeal cooling approach using cold and high air-flow rate reveals that it was 
possible to increase the brain-rectal temperature gradient in the heavier pigs compared to 
new-born piglets, i.e. 16 kg versus 2-3 kg. The rectal cooling rate was approximately one-
third of the corresponding brain cooling rate. Effective selective brain cooling was 
achieved with a median cooling rate of 2.3 ± 0.3°C/h in the juvenile pigs. 
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Figure B.1. Maximum cooling rate for brain as a function of different conditions in Nasal cooling. 
 Figure B.2(a,b) demonstrate the mean brain and rectal temperature profile as a 
function of time in both groups. Results shown in Figure B.2(b) demonstrated that 
maximum brain-rectal temperature gradient of -2.5°C reached about 20-30 min after the 
initiation of cooling and remained unchanged during the rest of nasopharyngeal cooling. 
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       (a) 
 
   N    (b) 
Figure B.2. Changes in the brain-rectal temperature over time for intra-nasal cooling method with 
setting the air flow rate to 14-15 L.min
-1
 for (a) piglets with average weight of ≈2-3kg; and (b) 
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juvenile pig with average weight of ≈16kg.  
B.3 Conclusions 
 We demonstrated that nasopharyngeal cooling by spraying humidified and cooled 
air into nasal cavities is an effective, safe and simple method to selectively reduce and 
maintain the brain-body temperature gradient in the heavier pig compare to new-born 
ones using heating blanket/sheets. 
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